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Despite significant developments in imaging modalities and therapeutics, 
mortality rates of cancer remain unchanged. It is known that detection and treatment of 
the disease before it has spread to other organs improves patient survival considerably. 
Nanometer-sized materials have unique optoelectronic and magnetic properties not 
available from their bulk phase. Since they are in the same mesoscopic size regime as 
biological molecules, they can be used to target and quantify individual molecules in a 
cell or in solution. In particular, semiconductor quantum dots (QD) are a new class of 
fluorophores that are bright, photostable, and can be simultaneously excited to emit 
different wavelengths of light. Magnetic iron oxide nanoparticles are another class of 
unique nanomaterials that exhibit superparamagnetism and are strongly magnetized 
only in the presence of a magnetic field. Early detection requires greater detection 
sensitivity, therefore there is a need for technologies that will not only permit detection of 
cancer but will allow the disease to be monitored through the expression of molecular 
markers. There is great potential for nanotechnology to meet this need, and if 
successful, it can make a significant impact on the cancer diagnostic landscape. 
In this dissertation, we describe the integration of semiconductor QDs and 
magnetic iron oxide nanoparticles and potential applications for (i) early detection of 
cancer biomarkers through routine screening, and (ii) disease monitoring through the 
capture and analysis of rare circulating tumor cells. First, we describe the development 
of integrated magneto-optical beads that can be optically encoded and magnetically 
separable for isolating low concentration of multiple biomolecules from solution. Iron 
oxide nanocrystals provide superparamagnetic properties for bead separation and target 
enrichment, but also attenuate the QD fluorescence intensity.  Nonetheless, we have 
 xix
prepared and characterized highly uniform dual-functions beads with three ratiometric 
signatures. Second, we demonstrate improved detection sensitivity by combining 
immunomagnetic beads and highly luminescent nanoparticles in a sandwich assay. 
Through the enrichment of protein from solution using magnetic beads and increased 
specificity from the dual-selectivity of the assay, we demonstrate detection sensitivity 
100-1000 times greater than solid-phase immunoassays.  
Next, we describe integration of magnetic and QD nanotechnology for the 
selective capture and molecular profiling of rare cells. We demonstrate the ability to 
spectroscopically determine relative molecular levels of markers to distinguish invasive 
cells from epithelial tumor cells. We also show breast cancer profiling that can enable 
one to determine most effective therapy.  
During the isolation of tumor cells from whole blood, we encountered non-specific 
binding of magnetic nanoparticles to leukocytes present in blood. Therefore, we studied 
nanoparticle-cell interactions using QDs to determine a solution to this problem. This 
was done by comparing QD association with cells as a function of surface coatings. Not 
surprisingly, we observed that anionic nanoparticles with carboxylic acid groups (-
COOH) strongly associated with leukocytes, but interestingly this association was cell 
specific. In the presence of plasma, they were uptaken by monocytes, whereas they 
were found in the perinuclear region of neutrophils (granulocytes) when plasma proteins 
were absent. Hydroxyl-modified QDs (QD-OH) were also compared with PEGylated 
micelle encapsulated QDs and showed little association with any leukocytes. From this 
study, we were able to conclude that by modulating the surface charge of nanoparticles, 
non-specific associations with cells can be controlled. Apart from improving magnetic 
nanoparticle coatings for more specific cell capture, this work also opens interesting 






 Metastatic cancer results when the disease spreads from a primary tumor site to 
vital organs and is responsible for most cancer deaths. Despite significant investment in 
developing novel cancer treatments, improvement in patient outcome remains modest. 
Most of this investment, both private and public, is directed towards improving current 
treatments and developing new ones against aggressive forms of cancer [1]. Given the 
incremental gains seen in therapeutics for advanced disease, it is unlikely that a “golden 
bullet” that will drastically reduce cancer mortality will materialize soon. Although the 
mapping of the human genome and developments in nano-scale polymeric drug delivery 
vehicles has opened new possibilities for targeted molecular therapeutics, its impact on 
the lives of cancer patients will not be known for the next 10 years. It is well known that 
detecting cancer at its earliest, most treatable stage gives patients the greatest chance 
of survival and so there should be a concerted effort in developing reliable early 
detection strategies for all types of cancer [2, 3]. According to latest estimates provided 
by the American Cancer Society, 560,000 Americans are expected to die of cancer in 
2007, which is equivalent to 4 jumbo jet crashes every day (1,500 deaths/day) [4]. 
Cancer is the second most common cause of death in the US after heart disease and 
accounts for 1 of every 4 deaths. Developing early detection technology and routine 
diagnostic assays to monitor treatment of currently used chemotherapies can reduce this 
mortality rate, as was the case for cervical cancer after the Pap smear test. Therefore, 
the potential impact of combining effective detection with therapeutics when the disease 
is confined to one organ is significant [1]. 
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 Research into tumor biology has revealed that cancer is a heterogeneous 
disease. Even within a single tumor, cells can show markedly different behaviors and 
can lead to varying prognoses. Long gone is the idea of cancer being a disease that is 
unique to tumor location. We now know that cancer is a collection of diseases that are 
going through several steps necessary to exhibit invasiveness. Tumor heterogeneity can 
be acute to the extent that neighboring cells in a tumor may appear morphologically 
distinct and not share the same genetic makeup[5]. This genetic instability together with 
the stochastic process in which cells transition from normal to highly invasive and 
immortal cells makes cancer detection an arduous task.  
 This molecular nature of cancer can be utilized to obtain real-time information of 
the state of the disease. The genes and proteins associated with tumor phenotypes 
represent biomarkers that provide correlation with cancer type, stage, and location[6]. 
The discovery of more than one biomarker implicated in cancer of a specific organ has 
led to development of multiplexed microarray technology to detect several biomarkers in 
one step[7-9]. As research in systems biology reveals the molecular pathways of the 
disease, quantitative data on the levels of these biomarker panels can provide us with 
useful information about the behavior and progression of the tumor. In turn, this will allow 
for personalized therapy and monitoring of patient response so that cancer can be 
tackled more effectively on an individual basis.  
 Compared to invasive procedures like needle biopsies, blood represents a 
relatively non-invasive source of information about the well being of the human body. 
With the advent of serum proteomics and the presence of elevated levels of cancer-
associated proteins in the blood of cancer patients, it will be possible to monitor these 
biomarkers on a routine basis and optimize treatment [10]. In this dissertation, we have 
made an attempt to address these requirements by combining two types of 
nanotechnologies that have the potential to impact the diagnostic landscape.   
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1.2 Scope and Organization 
 Detecting tumor-associated molecules and cells at the earliest disease stage will 
probably involve ultrasensitive detection technology since tumor cell and tumor-
associated molecule concentration in blood are likely to be very low. Further, the 
presence of a complex blood environment and non-tumor interfering factors make it 
more important to selectively isolate the targets. A technology that will permit enrichment 
of these molecules/cells from large sample volumes and permit their ultrasensitive 
detection will address this need.  
 Nanoparticles possess distinct optical, electronic and magnetic properties that 
are not available in the bulk phase [11]. Advances in nanoparticle synthesis have 
opened up a plethora of biomedical applications [12-18]. Additionally, the similarity in 
size between nanoparticles and biological molecules like DNA and proteins permits 
individual molecules to be probed. The size of nanoparticles also opens up interesting 
questions about their behavior and interactions with living systems. In the context of this 
dissertation, the hypothesis for a majority of this work is that although optical and 
magnetic nanoparticles can singularly offer the ability to improve on current detection 
technology, the integration of these two may enhance the overall detection sensitivity 
while providing quantitative information of targeted molecules. 
 This dissertation has been organized into 7 chapters. Chapter 2 provides a brief 
background about optical and magnetic nanotechnologies, and their combination. This 
chapter also provides the reader with a brief explanation of tumor metastasis, and 
nanoparticle-blood interactions. In Chapters 3 & 4 we discuss the development and 
applications of microbeads for early detection assays. In particular, Chapter 3 describes 
development of dual-function beads by embedding iron oxide nanoparticles and 
semiconductor quantum dots (QD) so that they can be optically encoded (for multiplexed 
analysis) and magnetically separable. Chapter 4 discusses the development of a 
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magnetic bead-based sandwich assay that utilizes luminescent nanoparticles (QDs and 
dye-doped nanoparticles) for ultrasensitive detection of biomolecules (protein and DNA) 
in solution. In chapters 5, we describe a method to quantify multiple biomolecules from 
circulating tumor cells by first enriching them with magnetic nanoparticles and profiling 
tumor biomarkers on the cell. During the course of this study, we encountered an issue 
of non-specific binding of nanoparticles to blood cells. Therefore, we have tried to 
understand these interactions in Chapter 6 by using QDs. Finally, in chapter 9, we 
provide a brief summary of the work included in this dissertation and discuss future 
directions that did not fall within the scope of this work.   
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 In the past, designing multi-functional nanoparticles has been hindered by the 
inability to synthesize monodisperse nanoparticles and precisely tune their 
optoelectronic and magnetic properties. Both semiconductor quantum dots and iron 
oxide magnetic nanoparticles possess unique properties that are unavailable in their 
bulk phases [1, 2] and each of these technologies has made a significant contribution to 
cancer detection [3-5], and even therapy [6-8]. In this chapter, we provide a brief 
overview of QDs, magnetic nanoparticles, and a review of current technologies 
incorporating both. Next, we provide the reader with a brief introduction to cancer 
metastasis, circulating tumor cell detection, and the major components of blood that can 
interact with nanoparticles. 
2.1 Magnetic iron oxide nanoparticles 
 The history of magnetism in civilization is ancient. More fascinating is the 
millennia old application of magnetite powder in medicine; the first medical use was 
reported in 10th century Egypt [9]. In recent times, the physics of magnetic nanoparticles 
has revealed interesting and unique properties that have opened up a diverse range of 
applications. Magnetic iron oxide nanoparticles with diameters less than 25 nm 
represent a new class of nanomaterials that possess properties that are not found in 
bulk iron oxide. These properties are directly dependent on size as magnetization and 
relaxation depend on particle volume (Equation 1). 
 
τ = τoexp(KV/kBT)        (1) 
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where K is the particle anisotropy constant, V is the particle volume, k is Boltzmann’s 
constant and T is temperature[10]. Therefore, as size (volume) is reduced, KV will 
eventually overcome thermal energy (kBT) causing magnetic moment of the particles to 
fluctuate. At a certain size (typically 25 nm for magnetite), the particle is said to 
superparamagnetic. As a result, the magnetic moment fluctuates rapidly in a random 
direction leaving a net moment of zero[11]. Such particles can then be strongly 
magnetized under external magnetic field yet exhibit now magnetic remnance when the 
field is removed. 
 For biomedical applications, the size limit for superparamagnetism is 
advantageous because it matches the size regime of most biomolecules such as 
proteins (5-50 nm) and is 1000-fold smaller than mammalian cells [11]. Together with 
their capability to be manipulated with external permanent magnets, they have been 
used in a plethora of applications such as bioseparation [12-17], biomolecule tagging 
and detection [18, 19], magnetic hyperthermia [20, 21] (destruction of targeted cells 
through heat generation in particles), in vivo cell tracking [22-24], MRI contrast 
enhancement  and drug delivery [6, 25, 26].  
 In particular, bioseparation applications are quite important because of the need 
to separate out low quantities of biological entities/targets from a large sample volume. 
Most often, these biological entities are in a complex environment containing millions of 
native molecules. Currently, detection of cancer-associated biomarkers and rare cells 
that are found in low amounts from bodily fluids is either laborious, time consuming or 
technically challenging. By attaching targeting moieties to magnetic nanoparticles, 
several groups have demonstrated enrichment of proteins [27-29], bacteria [30, 31] and 
cells [32, 33] with high degree of efficiency.  
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 When magnetic nanoparticles are placed in the presence of a homogeneous 
magnetic field, they experience a magnetic force that pulls them towards the magnet. 
This magnetic force can be described as follows. When a magnetic nanoparticle is 
dispersed in a diamagnetic medium like water, the force can be described by equation 
(2): 
 Fm = (m·∇)B          (2) 
Where, m is the magnetic dipole and B is the magnetic induction. In water, the total 
moment on the nanoparticle can be written as m = VmM, where Vm is the particle volume 
and M is its magnetization, which in turn is given by M = ΔχH, where Δχ is the particle’s 
magnetic susceptibility and H is the magnetic field strength [34]. Also, for conditions 
where nanoparticles are in dilute water solution, B = µ0H. When we put these relations 
together we get,  
 Fm = VmΔχ∇(1/2*B·H)        (3) 
When magnetic nanoparticles, tagged to a cell or molecules of interest, experience a 
magnetic force, they have to overcome hydrodynamic drag force and gravitational force. 
For small particles, gravitational force is negligible due to the low mass. Also, buoyancy 
force can affect motion due to the magnetic field but is also negligible in this case. 
Therefore, magnetic force has to overcome drag to enable particle to be pulled towards 
the magnet. This drag force can be described by equation 4, which is in fact the Stokes’ 
equation:  
  Fd = 6πηRmΔv         (4) 
Where η is the viscosity of medium, Rm is the particle radius and Δv is the relative 
velocity of the tagged cells (magnetic sedimentation velocity). If we equate (3) and (4), 
we get 
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         (5) 
Equation (5) can now be used to determine magnetic sedimentation velocity of 
nanoparticles as a function of size. Everything else remaining constant, the time required 
for magnetic nanoparticles to be sedimented completely (pulled towards magnet) is 
inversely proportional to the square of the radius. Larger microbeads, which are 
composed of thousands of magnetic nanoparticles enclosed in a polymer matrix can be 
sedimented in seconds, whereas individual magnetic nanoparticles will take hours. 
Depending on the application and the size of the target, nanoparticles or beads may be 
used. For example, in this dissertation, we have used nanoparticles to capture cells 
(Chapter 5) since the specific binding of several thousand nanoparticles on the cell 
surface results in quick sedimentation. However, for isolating biomolecules such as DNA 
and protein, we have used microbeads (Chapter 4) due to the inability to bind many 
nanoparticles to each molecule.  
Synthesis of magnetic nanoparticles 
 Influenced by progress made in the synthesis of other nanocrystals, such as 
quantum dots, magnetic nanoparticle synthesis has improved tremendously. In general, 
the two most common synthesis procedures involve decomposition of organometallic 
precursors, and the coprecipitation of iron salts in emulsions. When organometallic 
precursors are heated at high temperatures in the presence of organic surface 
coordinating ligands, it is possible to obtain iron oxide nanoparticles with tight size 
control (5-10% standard deviation in diameter)[35]. Hyeon et al. demonstrated synthesis 
of iron nanoparticles by the decomposition of iron pentacarbonyl[36]. Similarly, Sun et al. 
were able to produce magnetite nanoparticles of various sizes (2-16 nm) through a one-
step, highly robust procedure involving the reduction of iron (III) acetylacetonate in the 
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presence of oleylamine and oleic acid[37]. The resulting nanoparticles are stable, 
soluble in non-polar solvents and are resistant to oxidation. The size distribution and 




Figure 2.1 Transmission electron micrograph of iron oxide nanoparticles. These 
nanoparticles were produced by Fe(acac)3 decomposition in organic solvents. 
 
The nanoparticles produced by the above methods are coated with organic surface 
ligands due to association between the metal atoms, alkyl-amines (oleylamine) and 
alkyl-carboxylates (oleic acid) presents in the reaction solution. As a result they are only 
soluble in organic solvents[11]. For biomedical applications, they must be phase 
transferred into the aqueous phase using polymer coatings or ligand substitution 
procedures.  
2.2 Semiconductor Quantum Dots 
 Quantum dots (QD) are semiconductor inorganic nanocrystals that exhibit size-
tunable fluorescent properties. Recently they have garnered attention in the biomedical 
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science arena due to their superior photoluminescent characteristics compared to 
traditionally used organic fluorophores [1]. Although organic dye molecules are widely 
used in biological detection assays due to their availability, QDs are emerging as a 
comparable class of fluorophores[1]. Commonly available QDs that are used in biology 
are composed of CdSe nanocrystals capped with a thin layer of ZnS [38-40]. CdSe is 
typically used as the core because its band-gap energy spans the the visible region 
(400-800 nm) of the electromagnetic spectrum.  
 
Figure 2.2: Photoluminescent properties of QDs. Compared to organic dyes, QDs have (A) 
Broad absorption band and a narrow symmetric excitation peak [41]. (B) Exceptional 




 For most commercially available QDs, the emission wavelength is dependent on 
the physical size of the dots. In some cases emission can also be tuned by changing the 
composition of QDs. Therefore, it is possible to obtain a range of colors ranging from 
blue to red (Figure 2.2). QDs are superior to organic dyes in many ways. First, they are 
resistant to photobleaching and can be imaged for an extended period (up to several 
hours) making it useful for applications involving prolonged exposure to an excitation 
source[42, 44, 45]. Second, a single UV light source can excite QDs that emit different 
wavelengths of light. This is an important property as it allows for multiplexing and 
optical encoding[46]. Third, QDs have a broad excitation cross-section and a large 
Stoke’s shift which allows for high Signal-to-Noise Ratio (SNR) and reduced cross-talk 
between fluorophores. Lastly, QDs have a large excitation coefficient (in the order of 
100-1000 times more than fluorescent dyes) and as a result they are very bright [42, 47]. 
2.3 Bead-based assays 
 The growing popularity of bead-based assays in biology is due to several factors. 
Although microarray technology and other solid-phase detection technologies have 
successfully been employed for high-throughput multiplexed analysis, they suffer from 
detection sensitivity limits due to fixed surface area [48]. Bead assays are essentially a 
miniaturization of microarrays since each bead can be uniquely encoded for multiple 
targets [49, 50]. Unlike solid-phase biochips and microarrays, microbeads (micron-sized 
spherical particles) are easy to manipulate and provide much faster reaction kinetics due 
to their suspension in homogeneous solution and the associated advantages in diffusion 
rates.  In addition, microbeads have large surface areas and can be used to enrich 
target molecules and to increase the dynamic range of target detection. The material of 
the bead serves as a host to molecules and nanoparticles at very high densities, which 
enhances their individual properties considerably. Recently, optically encoded beads 
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have been developed for commercial flow cytometry based application. A popular 
example is the Luminex bead product [49, 51], which incorporates two dyes in varying 
ratios to produce 100 spectrally distinct microspheres. Similarly, QDs have been 
successfully incorporated producing intensely bright microbeads[43, 52-54].  
2.4 Magneto-optical nanotechnology 
 Exploration of potential applications of magneto-optical composite material has 
only recently been investigated. The primary motivation for research in this area is to 
combine the functionalities offered by each type of nanomaterial to address biomedical 
needs. In the case of magneto-optical technology, the goal is to obtain composite 
materials that can retain the nano-scale properties that each individual nanoparticle 
would otherwise have.  There are many exciting applications for these materials in the 
biomedical sciences. For example, by correlating the deep imaging capabilities of 
magnetic resonance imaging (MRI) with ultrasensitive optical imaging, a surgeon could 
visually identify tiny tumors or other small lesions during an operation and remove the 
diseased cells and tissue completely [4]. Medical imaging modalities such as MRI and 
PET can identify diseases non-invasively, but they do not provide a visual guide during 
surgery. The development of magnetic-QD hetero-dimer probes could solve this problem 
[55, 56]. Synthesis of composite materials at the nanometer [55, 57-65] and micrometer 
[66-68] scale has been demonstrated by various researchers. In some cases the goal 
has been to create nanoprobes that can emit a fluorescent signal and behave as a 
contrast agent for MRI applications. In other cases, the goal has been to create 
materials that can be magnetically manipulated yet exhibit favorable optical properties 
[66, 69-71]. For example, Su et al. described an elegant method to use immunomagnetic 
nanoparticles to capture E.Coli bacteria and detect them with great accuracy using QD 
[31].  
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2.5 Circulating Tumor Cells 
 Tumor metastasis involves a series of discrete steps that result in the 
dissemination of tumor cells to distant sites through the blood (Figure 2.3)[72]. First, the 
tumor cells must invade the tissue surrounding the tumor so as to obtain access to the 
blood vessels and lymphatic system. Upon circulation through the body, these circulating 
tumor cells (CTC) must extravasate into distant site and proliferate. In 1889, Paget 
described the metastatic process as a seed-soil hypothesis[73]. According to his 
hypothesis, just like seeds of a plant that are dispersed will only grow when they land on 
good soil, tumor cells are selective for the best environment where they can colonize 
and grow. The first attempts to detect these rogue circulating tumor cells from peripheral 
blood dates back to the 19th century when Ashworth observed tumor-like cells in the 
blood of cancer patients after autopsy [74]. Almost 80% of all tumors are epithelial in 
origin and will need to alter their morphology to detach from the tumor site and display 
enhanced mobility. Unfortunately, by the time metastasis is apparent a large population 
of cells have already disseminated into body fluids such as urine, sputum, and blood. At 
this stage, patient prognosis is poor and the administration of therapy is often futile. Most 
of these cells exhibit the same genetic characteristics that are found in cells at the 
primary tumor site. Sensitive assays are available such as mass spectroscopy and PCR 
but some of these assays are expensive to run, complex and technically challenging. 
Prior to the appearance of morphologically distinct features in precancerous lesions, 
several genetic mutations have already been taking place. 
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Figure 2.3: Schematic illustration of tumor cell dissemination from a local site to distant 
organs. The disseminated cells that are found in blood are called CTC (circulating tumor cells) 
and will eventually migrate from blood to a suitable environment and proliferate. Obtained from 
http://www.vitatex.com. 
 
 Therefore, a molecular assay needs to be developed that can intercept, enrich 
and perform molecular characterization of the cells undergoing a transition from 
precancerous to malignant phenotype. The National Cancer Institute (NCI) has outlined 
this transition phase as a “window of opportunity” that should be the focus of early 
detection assays. Needless to say, markers that can detect such cells need to be 
developed. In an important study conducted by Cristofanilli et al., levels of circulating 
tumor cells were quantified and correlated to disease progression and survival of 
metastatic breast cancer patients. The results showed that the number of CTC’s before 
therapy and after the first follow-up are useful predictors of overall survival[75]. In 
particular, a fascinating conclusion of this study was the fact that having more than 5 
cells per 7.5 ml of blood represented a cut-off point above which patient survival dropped 
drastically. Current methods for detecting circulating cells as tumor cells involve labor-
intensive and highly subjective techniques such as immunohistochemistry, FISH and 
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PCR. However, before any of the techniques can be used, the cells need to be enriched 
since there is a large discrepancy between the population of tumor cell and normal 
MNC’s in the blood. A significant challenge is the ability to isolate 1-10 tumor positive 
cells with a high degree of specificity[76]. Also it is imperative that no tumor cells are lost 
during enrichment. Flow cytometry has successfully been used for high-throughput 
analysis, but there is no morphological information that can be provided [77, 78]. Multiple 
color detection of cells with organic dyes is also possible but the inherent photostability 
problems associated with dye molecules make accurate quantitative analysis difficult. 
Overwhelming evidence suggests that there is an association between detection of 
tumor cell load and patient survival, and therefore it is worthwhile to invest efforts in 
developing tools to detect these cells [77, 79-83].  
2.6 Components of Blood 
 
Figure 2.4: Schematic illustration showing components of human blood. Human blood 




 Blood is complex biological medium comprising plasma, white blood cells, red 
blood cells and platelets (Figure 2.4). Due to their small size, nanoparticles have distinct 
properties that are not available in the bulk form of the same material. When 
nanoparticles are introduced into whole blood there are a plethora of interactions 
possible with these components. In particular, the small size and the tremendous 
increase in surface area lead to increased interactions with soluble plasma proteins. It is 
surprising that despite significant developments made in nanoparticles for biomedicine 
and diagnostic applications, relatively little is known about interactions of nanoparticles 
such as QDs with immune cells and proteins [84].  
 Leukocytes are mobile units of the body’s immune (protective) system. They are 
formed partially in the bone marrow and partially in lymph tissue. Most of them are 
specifically transported and activated in the presence of foreign agents, such as 
nanomaterials. There are six types of white blood cells normally found in the blood 
(Figure 2.5).    
 
 





The leukocytes are typically classified either by their appearance (granular vs. agranular) 
or by the presence of multiple nuclei. There are three types of polymorphonuclear cells 
that have a granular appearance; these are eosinophils, basophils and neutrophils. 
These cells are commonly categorized as granulocytes. Lymphocytes and monocytes 
are agranular cells with single large nuclei that comprise mononuclear cells. Additionally, 
there are a large number of platelets that are cell fragments of megakaryocytes. The 
adult human being has about 7000 blood cells per microliter of blood and 5 million red 
blood cells. The approximate percentage of the cells is shown in Figure 2.4. The 
number of platelets in each microliter of blood is normally 300,000. It should be noted 
that these percentages are approximate and vary from person to person under different 
physiological conditions. 
 Phagocytes are cells that ingest debris, dead cells and foreign particles (bacteria, 
nanoparticles) from blood through a process called phagocytosis (described in Chapter 
6). In the blood, the main phagocytes are neutrophils and macrophages/monocytes. 
Phagocytosis is an active process that helps to clear foreign substances from the 
circulatory system, and they play a crucial role in the removal of harmful substances. It is 
thought that the events mediating this process are closely connected to protein 
adsorption and tagging of the foreign agent with antibodies. Therefore, in order to design 
better nanoparticle probes for whole blood assays, and in vivo imaging, one needs to 
understand the relationship between these cells, the effector proteins and the 
nanoparticles. This will be explained in detail in Chapter 6.    
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DUAL FUNCTION MESOPOROUS MICROBEADS: OPTICALLY 
ENCODED AND MAGNETICALLY SEPARABLE FOR 
BIOLOGICAL DETECTION 
 
3.1 Introduction  
 Diagnosing complex diseases such as cancer at an early stage requires the 
ability to detect and quantify disease molecules in a rapid, efficient and reproducible 
manner. As we gain a better understanding of the molecular basis of cancer, it will also 
be important to detect multiple tumor-associated molecules in a one-step assay. Such a 
technology should be able to probe patient samples, such as blood that is accessible 
and obtainable in a non-invasive manner. Next, the technology should be able to detect 
rare number of molecules from a large sample volume. Solid tumors are in constant 
interaction with body fluids such as human blood and lymph as they gain access to 
soluble nutrients. Detection of low copy numbers of target molecules like protein 
biomarkers may involve analysis of large sample volumes. As a result, there is a need to 
develop technology for ultrasensitive disease detection from complex heterogeneous 
biological samples.  
 High throughput and rapid assays that can detect multiple target molecules 
simultaneously with high sensitivity are desirable for many analytical applications. 
Micrometer-sized spherical beads are increasingly being used for such assays since 
their suspension in solution permits faster reaction kinetics [1-9]. Moreover, they can be 
physically manipulated and can offer a greater dynamic range of target detection (due to 
large surface area) compared to solid state microarray chip based assays. Enabling a 
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high throughput detection system requires encoding a set of beads uniquely so that they 
can bind to an assigned target, be captured and decoded accurately.  
 The application of magnetic beads for the isolation, or enrichment of a cell [10-
12], protein [9, 13-15], or DNA [16, 17] of interest, has been well known. In fact, several 
commercial kits are now available for magnetic separation using beads[18]. In some 
instances, beads are in the nanometer size range whereas in others, they are in the 
micrometer range. Most beads are developed by loading superparamagnetic 
nanoparticles into a host material that is well sealed to prevent exposure and leakage of 
the nanoparticles to the environment. An important requirement of such beads is to have 
no magnetic remnance upon removal of a magnetic field.  
 In a similar vein, the development of optical beads has allowed for the 
multiplexed detection of several biomolecules in one step using spectroscopic methods 
and flow cytometry. Recently, there have been numerous reports of optical beads that 
can be encoded with QDs thereby making it possible to uniquely code several thousand 
beads [5, 19-22]. A similar approach using organic dye loaded microbeads has 
successfully been translated to the commercial sector and is widely used for high-
throughput flow based detection of cytokines in solution [4]. Our hypothesis is that 
combining these two properties of magnetic and optical beads into one composite 
material will greatly enhance detection sensitivity due to magnetic enrichment strategies 
while still maintaining multiplexing capability. The magnetic properties of the bead will 
also allow for external manipulation and isolation of beads for other applications. 
Moreover, as flow-based magnetophoresis technology improves, our beads have the 
potential to increase the degree of multiplexing by adding a magnetic encoding 
parameter to existing optical encoding by QDs. 
 In this chapter, we describe the preparation of dual-function optical and magnetic 
beads, and also report two-color optical encoding and rapid magnetic bead separation.  
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In comparison with other work in this area [12, 19, 23-28], we have used mesoporous 
beads to incorporate both types of nanoparticles through hydrophobic interactions.  Due 
to the highly porous internal structure and very large surface area [29], these 
mesoporous beads (with pore sizes ranging from 2-100 nm) allow up to one million 
nanoparticles to be incorporated into a single micrometer-sized bead. 
3.2 Methods 
Materials 
 (All chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless stated 
otherwise.) Iron oxide (Fe3O4) magnetite nanocrystals with an average diameter of 6 nm 
(4-5% size variations) and coated with oleic acid and oleylamine were synthesized 
according to the procedure by Sun et al. [30] The initial nanocrystals were dispersed in 
hexane. Core-shell ternary quantum dots [31] dispersed in toluene and coated with tri-n-
octyl phosphine oxide (TOPO), were provided by Crystalplex Corporation (Pittsburgh, 
PA). In addition, CdSe/ZnS core-shell quantum dots were synthesized according to 
literature procedures. [32] C18 (octadecyl) chain derivatized mesoporous silica 
microbeads (3-5 µm) were obtained from Alltech Inc. (Deerfield, IL).  The average pore 
diameter of these beads is about 30 nm, but the random pore size distribution means 
that a collection of small and large pores co-exist that may be “interconnected” with each 
other. This pore structure not only allows rapid partitioning of nanocrystals into the 
mesoporous structures, but provides nanocrystals with a larger surface area for binding. 
Bead concentrations were determined by using a hemacytometer. 
Bead Encoding and Doping 
 The doping procedure for preparing dual-function beads involved addition of 10 
µl of 32- nM iron oxide nanocrystals and 2 µl of 100 nM quantum dots (QD) either in 
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sequence or simultaneously to a well-mixed solution of 1.5 million silica beads dissolved 
in 0.5 mL butanol. The solution was vigorously stirred for 15-20 minutes, and was then 
placed on a 1.5 Tesla NdFeB permanent magnet (MCE Products, Torrance, CA).  A 
brownish pellet was observed at the side of the tube within 10 seconds. Supernatant 
was removed and the sample was washed 2-3 times in ethanol to remove free 
nanocrystals. Free iron oxide nanocrystals that are not be incorporated in the beads 
experience a much lower magnetic force in presence of a magnet compared to several 
thousands packed in a bead. These nanoparticles will therefore not pellet as fast as the 
beads and can be pipetted out along with the supernatant. This washing step is essential 
as it aids in partitioning any remaining quantum dots into the highly hydrophobic porous 
sites of the bead. Non-magnetic beads used in bead separation efficiency studies were 
prepared according to Gao et al.[21]. These beads had to be pelleted by standard 
centrifugation since they cannot be magnetically manipulated. For sequential doping 
studies, a large batch of QD-doped beads were first prepared by mixing 5 µl of 100 nM 
QD with 50 µl bead solution (concentration of 5.15 x 105 beads /µl) in 0.5 mL 1-butanol. 
Each resulting bead contains approximately 13,000 QD’s. The bead solution was then 
aliquoted into 8 equal volumes containing about 3.2 million beads and iron oxide 
nanocrystals were added in increasing amounts (i.e., 2 µl, 5 µl, 10 µl, 20 µl, 30 µl, 50 µl, 
100 µl of 32 nM iron oxide) to each of the aliquots. 
Optical Microscopy 
 Fluorescence images of individual beads spread on coverglass (Corning, 
Corning, NY) were obtained with an Olympus IX-70 inverted epifluorescence microscope 
(Olympus, Melville, NY) equipped with Nikon D1X digital CCD camera, broad-band 
100W mercury arc lamp with a blue light BP460-490 excitation filter (Chroma Tech., 
Rockingham, VT), a DM500 dichroic mirror and 520LP long pass emission filter (Chroma 
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Tech, Rockingham, VT). Wavelength-specific single-bead fluorescence spectra were 
obtained with a single stage SpectraPro 150 spectrometer (Roper Scientific, Trenton, 
NJ) connected to the side port of the fluorescence microscope. A schematic of the setup 
is seen in Figure 3.1.  
 
 
Figure 3.1: Single bead spectroscopy setup used for obtaining fluorescence spectra. By 
using a pinhole in between the microscope port and spectrometer, one can obtain fluorescence 
spectra from a single bead. 
 
Polymer Coating 
 Hydrophobic bead surface was made hydrophilic by using octylamine poly 
(acrylic acid), an amphiphilic polymer prepared by modifying 40% of the carboxylic acid 
groups of polyacrylic acid with octylamine.  Thus, hydrophobic beads were added to a 
50:50 mixture of Triton X-100 and octylamine poly (acrylic acid).  Absence of Triton X-
100 surfactant led to poor bead stability and aggregation. The polymer-coated beads 
were dispersed in PBS with 0.02% Tween 20.  
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Bead Counting and Data Analysis 
 True color fluorescence images were obtained and beads counted using a data 
visualization and image analysis software package (Interactive Data Language or IDL, 
Research Systems Inc., Boulder CO). An astrophotometry package, DAOPHOT [33] 
which operates in IDL, was adapted for image processing to locate particles accurately.  
Threshold values were set for red and green channel images so that red and green 
beads could be accurately counted. Beads were then visually counted from the image to 
match up the results. The threshold settings led to an error of less than 3-4% in the 
number count. The separation efficiency is based on the removal of non-magnetic 
material from a solution containing magnetic beads. In our study, green non-magnetic 
beads were counted before and after separation. The number of beads before 
separation was divided by the initial number of beads, and multiplied by 100 to obtain 
the percentage. 
Flow Cytometry 
 In order to assess the intensity-based encoding of the dual function beads, two 
sets of beads were created, having two different intensity levels of a single color. For this 
study, quantum dots with an emission maximum of 585 nm were used to encode the 
beads. The iron oxide nanoparticle concentration was kept constant and the beads were 
doped sequentially. QD intensity was obtained using a preset Phycoerythrin (PE) filter 
setting on a FACSAria flow cytometer (BD Biosciences, Franklin Lakes, NJ) as a 
function of side-scattering. The excitation source was a 405 nm violet laser. Scatter plots 
displaying side scattering as a function of PE signal intensity (QD) were plotted using 




 Precaution must be taken while handling QDs due to toxic nature of cadmium 
contained in the dots. Standard safety guidelines must be followed to prevent QDs from 
contact to skin. Supernatant containing excess QDs must be disposed off in organic 
solvent waste container according to OSHA guidelines. If the silica microbeads are 
provided in powder form, a respirator may help reduce possibility of silicosis through 
inhalation. There is no danger of inhalation of nanoparticles since they are synthesized 
in solution phase. 
 
3.3 Results and Discussion 
Bead Preparation 
 Silica beads derivatized with C18 alkyl chains offer a strongly hydrophobic 
environment for the incorporation of TOPO-coated QDs and oleic acid coated-iron oxide 
nanoparticles. The rapid partitioning and entrapment of nanoparticles throughout the 
bead make it possible to create a large number of uniformly doped beads in a short 
period (20-30 min). Bead doping can be accomplished in two ways: simultaneous 
incorporation by using pre-mixed nanoparticles, or sequential incorporation by adding 
QDs and iron oxide nanocrystals separately (Figure 3.2A).  The choice of a particular 
doping scheme is largely determined by two factors: (i) the desired functionality and (ii) 
interaction amongst nanoparticles embedded in the bead. The physical size and surface 
chemistry of nanoparticles are important when incorporating them in a bead since 
dissimilar sizes or surface chemistries may lead to variations in doping kinetics and 
stability. Instead of traditional CdSe/ZnS core-shell QDs that have size-dependent 
photoluminescent properties, we have used ZnS capped ternary CdSSe alloyed TOPO-
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coated QDs with composition-tunable optical properties at constant particle sizes [31]. 
Similarly, monodisperse iron oxide (magnetite; Fe3O4) nanocrystals, coated with 
hydrophobic oleic acid and oleylamine are synthesized such that they have the same 
physical size (6 nm) as QDs.  
  
 
Figure 3.2: Schematic diagrams illustrating the preparation and the internal structure of 
dual-function optical and magnetic mesoporous beads. (A) Sequential and simultaneous 
incorporation of quantum dots and iron oxide nanocrystals into the nanoscale pores of silica 
beads.  (B) Internal structure of encoded beads with strong interactions between hydrophobic 




 The hydrophobic nanoparticles most likely interact strongly with the beads’ 
porous network (Figure 3.2B). The internal structure, studied using TEM (Figure 3.4) of 
bead thin sections, reveals a highly porous structure with random pore size distribution. 
This random size may be beneficial for doping as the tortuosity and irregular surface of 
the pore allows stronger binding of nanoparticles to the pore surface by polyvalent 
interactions (that is, multiple ligands on the nanoparticle surface interacts with multiple 
C18 hydrocarbon molecules on the pore wall). Upon doping, beads suspended in 
solvent can be quickly washed by pulling them to the side of a microcentrifuge tube 
using an inexpensive permanent magnet and removing the supernatant. Consistent with 
this strong binding model, we found no trace of nanoparticle leakage from the beads into 
solvents such as water and ethanol (determined by fluorometric analysis of the solvent 
after washing). In the final step, the encoded hydrophobic beads are made hydrophilic 
by using an amphiphilic polymer, which is essential for conjugation to biomolecules and 
to minimize nonspecific binding. 
 For high throughput multiplexed analysis, the encoded beads should have 
uniform brightness. Fluorescence microscopy was performed on beads doped with QDs 
emitting at three wavelengths, either containing or not containing iron oxide (Figure 3.3). 
From the images, it is clear that the addition of iron oxide does not cause visible 
aggregation or clustering of QDs in the bead. Further, the superior QD brightness allows 
for easy visualization of beads that are magnetically addressable. Based on QD doping 
studies (performed by fluorometric analysis of QDs remaining in solution after bead 
doping), we have calculated that each bead, with 30 nm pore size, can roughly 
accommodate 0.3 to 0.4 million nanoparticles (diameter = 6 nm). This high loading 
capacity together with the high extinction coefficient of QDs implies that only a small 
fraction of binding sites need to be occupied by QDs. This permits other types of 
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nanoparticles to occupy the remaining binding sites. We estimate that occupation of 10-
15% of sites with QDs is enough to accurately encode an optical signature. 
 
Figure 3.3: True color fluorescence images of encoded beads. (A-C) non-magnetic, and (D-
F) magnetic QD-encoded beads. Mesoporous silica beads with a diameter of 4.0 nm were doped 
with single-color ternary quantum dots emitting at 530 nm (A,D), 590 nm (B,E), and 630 nm (C,F). 
White scale bar represents 4 µm. 
 
 Supplementing the encoded beads with extra functions through the addition of 
nanomaterials, could possibly compromise optical characteristics that are vital for 
decoding the spectroscopic signatures. In particular, coupling interactions between iron 
oxide and QDs is important to optimizing the optical and magnetic properties of the dual-
function beads, as discussed below. 
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Figure 3.4: Transmission electron micrographs of magneto-optical bead sections. (A) 
Nanocrystals are distributed uniformly throughout the bead, although higher concentrations can 
be seen at the surface (B) High magnification image shows highly porous structure of beads 
necessary for allowing doping of high number of nanocrystals. (C) Fluorescence image of 200 nm 
thick sections of beads in immobilizing resin. Yellow color QD encoded beads were used but 
show weak signal due to background autofluorescence. Beads appear to be uniformly doped with 
QD although there are some variations in intensity possibly due to non-uniform internal structure 
of beads. 
 
 Upon preparation, beads were sectioned to reveal internal distribution of 
nanoparticles. Figure 3.4A shows a TEM image of 60-70 nm thick bead sections, with a 
magnified view (Figure 3.4B) showing the highly porous structure of the beads. 
Although these beads have an average pore size of 30 nm, the random pore size is 
evident from the TEM images. Also, pores inside the bead appear to be interconnected, 
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forming a porous network, which would explain the incredibly fast rate (15-20 mins) at 
which nanoparticles partition into the beads.  Moreover, the porosity of the bead doesn’t 
seem to vary from the center to the periphery, which is important for uniform distribution 
of nanoparticles. From Figure 3.4A and 3.4B it is hard to confirm nanoparticles 
distribution in the interior due to high background from electron dense silicon. Therefore, 
bead sections of dual-functional beads were imaged under wide-field fluorescence 
illumination (Figure 3.4C) and show even distribution across the diameter, although net 
fluorescence may vary from bead to bead. 
Effect of Iron Oxide on QD Fluorescence 
 To examine the effect of iron oxide on QD signal intensity, increasing 
concentrations of iron oxide were added to QD-doped beads in a sequential manner, 
and fluorescence spectra (Figure 3.5A) were recorded using single-bead spectroscopy.  
Statistical error analysis of the fluorescence intensity measurement was obtained from at 
least 25 single-bead spectra for each bead sample (Figure 3.5B). The results indicate 
that the embedded iron oxide significantly reduces the QD fluorescence intensity.  A 
parallel study using the simultaneous doping procedure yielded a similar drop in 
fluorescence intensity. Although there is no shift in the emission spectra, they are not as 
symmetric as that for free QDs. This is evident by the longer tail towards the red-end of 
the visible spectrum. There are several possible explanations for this effect: first, the 
embedded iron oxide nanocrystals could quench QD fluorescence through electronic 
coupling and energy transfer; second, the embedded QDs could be replaced by iron 
oxide nanocrystals during sequential incorporation; and third, the embedded iron oxide 
absorbs broadly in the visible spectrum, and could thus attenuate both the excitation 
light and the emitted QD fluorescence.   
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Figure 3.5: Effect of embedded iron oxide nanocrystals on QD fluorescence in dual-
function mesoporous beads. (A) Fluorescence emission spectra obtained from single beads 
doped with increasing amounts of iron oxide. (B) Statistical analysis of bead (n = 25) fluorescence 
intensity as function of iron oxide concentration. For both (A) and (B), one unit (1x) is equal to 62 
femtomoles of iron oxide nanocrystals, corresponding to 6,000 nanocrystals per bead. Error bars 
signify standard deviation. All beads contained the same amount of QDs (approximately 13,000 
QDs per bead). 
 
 The first possibility can be ruled out because similar decreases were observed in 
dilute solutions of simple QD and iron oxide mixtures. In this case, the large distances 
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between QD and iron oxide particles should prevent energy transfer.  Also, a quenching 
mechanism does not explain the non-symmetric fluorescence peak.   
 
Figure 3.6: Spectroscopic analysis of quantum dots in the presence of iron oxide (A) 
Absorption profiles of quantum dots in the absence and presence of iron oxide. Also shown is the 
emission spectrum of a dual-function optical and magnetic bead. (B) Fluorescence intensity as a 




 The second possibility can also be ruled out because no replaced QDs were 
detected in the supernatant. Furthermore, simultaneous incorporation of QDs and iron 
oxide particles leads to similar fluorescence decreases. We believe that the iron oxide 
optical absorption is mainly responsible for the observed interference of iron oxide on 
QD fluorescence.  To further study this effect, we obtained fluorescence spectra and 
absorption profiles of QDs mixed in solution with increasing levels of iron oxide. In 
agreement with previous studies, [34] iron oxide nanocrystals show a broad absorption 
spectrum in the visible range (400 nm – 600 nm) (Figure 3.6A), perhaps due to charge 
transfer transitions in this mixed-valence compound. As expected, excitation light in this 
window will be strongly absorbed by iron oxide, thus attenuating the light intensity 
reaching the embedded QDs.  Because the iron oxide absorption spectrum decreases 
gradually to the red, excitation at longer wavelengths should lead to smaller intensity 
attenuations.  Indeed, when excited with green (560 nm) light instead of blue (480 nm) 
there is significantly less attenuation of fluorescence intensity (Figure 3.6B).  In addition, 
a fraction of photons emitted by QDs could be absorbed by iron oxide in a wavelength 
dependent manner. This absorption is most likely responsible for the slight asymmetric 
shape (“tailing” at longer wavelengths) of QD fluorescence in dual-function optical and 
magnetic beads. 
Ratiometric Bead Encoding 
 Figure 3.7 shows representative spectra from beads doped with QDs emitting in 
the green and red wavelengths. Based on two intensities, there are three ratios that can 
be used to encode beads. Variations in the ratio for the beads are roughly 15% and can 
be attributed to two factors. First, there could be differential adsorption of iron oxide in 
beads as a result of size differences. Second, given that iron oxide absorbs strongly in 
the blue region, variations in iron oxide concentration could lead to a population of beads 
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with variable green QD signal intensities. This proof-of-concept study demonstrates that 
it is indeed possible to prepare dual-function optical and magnetic beads encoded with 
three different and discernable spectroscopic signatures. 
 
 
Figure 3.7: Two-color QD encoding of dual-function beads using green (530 nm) and red 
(630 nm) emitting dots. Horizontal error bars indicate variances in the ratio of green to red 
fluorescence intensities of single beads on a logarithmic scale. Log error bars were computed by 
calculating standard deviation of the log of intensity ratios and representing as a horizontal bar in 
logarithmic scale. As a reference, log of 1:2, 1:1 and 2:1 ratios are -0.301, 0, and 0.301 
respectively. 
 
Flow Cytometry Analysis 
 So far, we have demonstrated that mesoporous beads can be uniquely encoded 
by emission wavelength of QDs or by intensity of each emission color. We decided to 
test the ability to discriminate dual function beads encoded with a low or high intensity of 
a single color using flow cytometry. Biologists, immunologists and biochemists routinely 
use flow cytometry as it can be used to quantify the number or expression patterns of 
mammalian cells. Microbeads used in our studies are similar in size to these cells and 
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can be easily detected by the PMT’s and filter sets in standard flow cytometers. Two 
sets of beads either having low or high fluorescence intensity of QDs emitting at 580 nm 
were prepared and verified visually under an epifluorescence microscope. Three 
samples, each of the sets and one containing a 50:50 mixture of both were prepared and 
run. A phycoerythrin (PE) filter set and channel was used to analyze side scatter and a 
scatter plot was generated (Figure 3.8). 
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Figure 3.8: Flow cytometry analysis of dual function beads encoded by color intensity. 
Side scatter plots of beads exhibiting (A) low and (B) high fluorescence intensity and (C) a 
mixture of both low and high intensity. 
 
 Magnetic Bead Separation 
 To study the efficiency of magnetic bead separation, we mixed red-QD encoded 
magnetic beads with green non-magnetic beads (Figure 3.9A).  Upon placing the 
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solution on a magnet for 5 minutes, and removing the supernatant, beads were re-
constituted to the initial volume and imaged using a standard fluorescence microscope 
with blue-light excitation.    
 
Figure 3.9: Fluorescence microscope images showing efficient separation of magnetic and 
nonmagnetic QD-encoded beads. (A) Mixture of magnetic red-QD beads and nonmagnetic 
green-QD beads spread on a glass coverslip. (B) After magnetic separation and washing to 
remove the nonmagnetic beads. 
 
 Prior to this, beads were water solubilized for two reasons. Firstly, bead 
separation efficiency cannot be calculated when using ethanol as a solvent since the 
hydrophobic beads tend to cluster and can bind to a cluster of non-magnetic beads. A 
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non-polar solvent cannot be used either because nanoparticles could leach out of the 
bead. Secondly, viscosity of the solvent affects magnetophoretic mobility (See Stokes’ 
drag force (FD) relationship, Equation 4, Chapter 2). Therefore time of separation in 
various solvents may provide misleading data. Ultimately, it is essential to calculate the 
efficiency in an aqueous solution as we see great promise for this technology in 
biological separation of cells and molecules. In order to calculate the efficiency in a fast 
and accurate manner, magnetic and non-magnetic beads were color coded and mixed 
such that non-magnetic beads were in large excess. Figure 3.9A is an image of the bead 
mixture prior to separation. Using an NdFeB permanent magnet, beads were allowed to 
be pulled towards the magnet for 5 minutes. In reality, a large bead pellet was seen near 
the magnet wall within 20-30 seconds, unlike the 20 minutes[35] and few hours[25] 
reported elsewhere. After a single wash with PBS buffer, an equal volume of bead 
sample was immobilized on a coverslip and imaged as shown in Figure 3.9B. The 
images were quantified for total bead populations using a particle counting software.  
The results were matched with manual counting to confirm veracity of the data. 
From the results shown in Figure 3.9, the efficiency of bead separation is almost 99% 
after a single wash. Additional washes were not performed but a total of three washes 
will ensure that essentially all non-magnetic material is removed. The results clearly 
show separation of the red and green beads.  We used a computer program to count the 
number of red and green pixels above an intensity threshold, and the automated 
counting data show that the separation efficiency is better than 99% (calculated by 
dividing the number of non-magnetic beads after separation by the initial number of 
beads before separation, and multiplying this by 100). 
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Figure 3.10: Rapid separation of dual function magnetic and optically (QD585) encoded 
beads. Bright field image of bead suspension in water at (A) t  = 0 seconds and (B) t = 50 
seconds. (C, D) Dual function beads under UV excitation initially, and after placing next to a 
permanent magnet. 
 
The efficiency of magnetic separation will of course depend on the iron oxide 
concentration in the beads. Beads containing more iron oxide nanocrystals (3 x 105) and 
encoded with ternary QDs emitting at 580 nm were prepared. These beads were rapidly 
pulled towards the permanent magnet and the corresponding images are shown in 
Figure 3.10. As more iron oxide nanocrystals are packed into a bead, the total magnetic 
force experienced by the bead increases, thereby increasing net magnetization. We 
estimate that about 105 iron oxide nanocrystals per bead, as used in this experiment, are 




Figure 3.11: Water soluble dual function beads. Magnetic and optical beads coated with poly 
(acrylic acid) modified with octyl amine and encoded with (A) 630 nm emission ternary QDs and 
(B) 580 nm ternary QDs. 
 
Beads were solubilized in water by adding them to a 50:50 mixture of Triton X-
100: Poly(acrylic acid) with 40% carboxyl groups modified with Octylamine using 
Dicyclohexylcarbodiimide (DCC) based coupling. Beads were precipitated with a magnet 
and solvent was removed before the addition of surfactant-amphiphilic polymer mixture. 
Absence of Triton X-100 surfactant results in poor bead stability and particles begin to 
aggregate. The resultant beads are dispersed in PBS with 0.02% Tween 20 and have 
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functional groups that can be used for conjugating biomolecules to the surface. 
Additionally, electrostatic interaction can be employed to attach positively charged 
biomolecules to the surface consisting of negatively charged carboxyl functional groups. 
 In conclusion, we have prepared dual-function optical and magnetic beads by 
incorporating monodisperse QD and iron oxide nanocrystals into mesoporous silica 
beads. Iron oxide nanocrystals provide superparamagnetic properties for bead 
separation and target enrichment, but also attenuate the QD fluorescence intensity.  
Nonetheless, we have prepared and characterized highly uniform dual-functions beads 
with three ratiometric signatures. We have also achieved rapid separation of magnetic 
and nonmagnetic beads at better than 99% efficiencies, allowing enrichment of targets 
and reduction of background signals. Development of more complex multifunctional 
beads is also possible due to the large doping capacity of porous beads. In addition, we 
expect that encoded mesoporous beads could be used for automated detection 
technology, as well as microfluidic devices for multiplexed and ultrasensitive detection of 
cancer biomarkers from body fluid samples. In the following chapter, we discuss a bead-
based assay using magnetic beads and luminescent nanoparticles to demonstrate the 
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SINGLE-BEAD BASED ASSAYS USING MAGNETIC 
MICROBEADS AND LUMINESCENT NANOPARTICLES 
 
4.1 Introduction 
 As discussed in previous chapters, there is a need to develop an assay that can 
detect low copy number of molecules from a large sample volume (low concentration). 
Although solid-phase assays such as Enzyme-Linked Immunosorbent Assay (ELISA) 
and DNA microarrays are tools that are increasingly being used for basic research, 
pharmacological screening and clinical diagnostics, they suffer from limitations in 
flexibility, cost, and sensitivity. Our hypothesis for this work is that bead-based assay has 
the potential for high sensitivity screening of DNA fragments and proteins in solution. In 
the previous chapter, we discussed the development of bead-based technology with the 
potential for multiple molecule detection by combining unique properties of magnetic and 
optical nanoparticles. Here, we demonstrate application of similar technology towards 
detection of rare protein and DNA molecules using magnetic-bead and optical readout 
sandwich assay.  
 Magnetic beads have been used in the past decade for target enrichment. In fact, 
magnetic beads with different functional groups (-NH2, -COOH, Streptavidin, Tosyl 
group) are commercially available from a variety of sources [1, 2]. The major advantage 
of magnetic beads is that it allows for captured target molecules to be isolated and 
enriched without the need of centrifugation or column chromatography. This allows for 
fragile biomolecules to be enriched without causing any damage [2]. Enrichment of 
target and reduction of sample volume leads to increased local target concentration and 
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improved detection sensitivity. Further, improvements in bead synthesis chemistry have 
made it possible to produce beads with high degree of uniformity, smooth surface for 
attachment of targeting ligands, and elevated target binding kinetics (reaction limited as 
opposed to diffusion limited) compared to solid-state arrays such as ELISA [3]. Antibody-
coated magnetic beads have been successfully used in capture and quantitative 
analysis of proteins [1, 4-10], nucleic acids [3, 11, 12], and infectious diseases [13-17].  
 Most of these studies have depended on chromophores or fluorescent molecules 
to quantify target concentrations. Fluorescence-based assays offer much higher 
detection sensitivities compared to colorimetric assays, however the inherently poor 
photostability of commonly used organic dyes diminishes this sensitivity. Fluorescent 
nanoparticles such as QDs and dye-doped nanoparticles have been successfully 
demonstrated in ultrasensitive detection formats [18] due to their extended photostability 
and greater brightness [19, 20]. In this chapter, QD and dye-doped nanoparticles 
(hereon referred as Luminescent Nanoparticles; LNP) are used as external probes for 
target quantification. A bead-based sandwich immunoassay for detection of tumor-
associated protein TNF-alpha is demonstrated here. Standard fluorescence microscopy, 
spectroscopy and image analysis is used to analyze and quantify single beads and 
determine target concentration based on total fluorescence intensity. Additionally, we 
also report preliminary results for oligonucleotide detection at nano-molar concentrations 





4.2 Materials and Methods 
Magnetic bead conjugation 
 Approximately 6.7 million magnetic beads (Streptavidin-coated magnetic 
Dynabeads M-270 (Invitrogen) 2.8 um in diameter, were first washed with washing buffer 
composed of 10 mM Tris-HCl (pH 7.5), 1mM EDTA and 2.0 M NaCl, followed by  
blocking buffer (BlockAid Buffer, Invitrogen). All washing steps were performed in a 1.5 
mL Eppendorf tube by pulling beads to the side-wall of the tube with a permanent 
magnet (1.5 T Sintered Neodymium Iron Boron Magnet, MCE Magnets Inc., Torrance, 
CA) and removing supernatant. This was followed by incubation at room temperature 
with either biotinylated anti-TNF-alpha antibodies (20 ul of TNF-alpha antibody 
(concentration = 0.5 mg/mL, T-9160-14d, U.S.Biologicals, Swampscott, MA) for protein 
detection assay, or with biotinylated oligonucleotides (get sequence from lab, TriLink 
Biotechnologies, San Diego, CA) for DNA detection. Upon incubation for 30 minutes 
under gentle shaking, beads were washed three times with PBS Buffer (10 mM, pH 7.4) 
to remove unbound antibody or DNA molecules. An excess of avidin was added to 
saturate any free biotin sites at this point. 
Optical probe conjugation  
 For QD conjugation, 10nM of streptavidin-coated QDs (Invitrogen) with emission 
maxima of 525 nm were coupled with biotinylated oligonucleotides having a sequence 
complimentary to that attached on the magnetic bead. A 1:5 molar feed ratio of QD:oligo 
was used for reactions. After incubation at room temperature for 1 hour, unbound oligos 
were purified by filtration through an S-300HR size-exclusion chromatography filtration  
column (GE Healthcare, Piscataway, NJ). Purified samples were qualitatively tested by 
running them through a 0.8% agarose gel in 0.5X TBE Buffer for 1 hour at 100V. 
Compared to plain streptavidin-coated QDs, the DNA-conjugated QDs migrated faster to 
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the cathode. (Tetramethylrhodamine and biotin-labeled dextran (Invitrogen Inc.) were 
also used to test the detection limit using identical experimental procedures. 
 Carboxylate-modified yellow/green FluoSpheres (F8795, excitation/emission 
505/515, 43 nm diameter, Invitrogen Inc.) were conjugated to monoclonal murine TNF-
alpha antibody (T9160-16A, 1 mg/mL, U.S. Biologicals Inc.) using an aqueous-based 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC; Sigma-Aldrich) 
coupling reaction [21]. Specifically, 5 µL of the FluoSphere stock solution was added to 
40 µL of 25 mM MES buffer (pH 5.9), and the mixture was sonicated for 15 min. Next, 
the EDC solution at a concentration of 5 mg/mL (20 µL, 100 µg total) was added to the 
bead solution and was vortexed for 15 min. Similarly, 11 µL of N-
hydroxysulfosuccinimide (sulfo-NHS; Thermo-Fisher Scientific, Rockford, IL) at 14 
mg/mL concentration was added to the bead solution and was vortexed for 15 min. 
Thereafter, 2.5 µL of TNF-R antibody at a stock concentration of 1 mg/mL was added to 
the solution and vortexed for 1 h. Next, 100 µg of EDC (as freshly prepared solution in 
MES buffer) was added, and the solution was vortexed for 75 min (total reaction volume 
was 100 µL). Finally, the reaction product was filtered by using an S-400 HR size 
exclusion filtration column (GE Healthcare, Piscataway, NJ) to remove unreacted 
antibody molecules. 
Assay procedure 
 One microliter of magnetic microparticle (MMP)-antibody conjugates was mixed 
with recombinant murine TNF-alpha molecule (R&D Systems Inc., Minneapolis, MN) in 
various concentrations (from 6 x 10-9 to 10-17 M) in 1 mL of PBS buffer (10 mM PBS, pH 
7.4 + 0.1% BSA + 0.02% sodium azide +0.02% Tween 20) and was allowed to react 
with vigorous stirring at room temperature for 2 hours. The MMPs were pulled down 
using a 1.5 T magnet (Sintered Neodymium Iron Boron Magnet, MCE Magnets Inc.) and 
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were washed three times with the PBS buffer. The MMPs with TNF-alpha molecules 
captured on their surfaces were resuspended in 90 µL of PBS buffer and were allowed 
to react with 10 µL of Fluosphere-antibody conjugate with vigorous vortexing for 1 h at 
room temperature. Finally, the reaction product was pulled down using magnet, washed 
two times with the PBS buffer, and concentrated to 10 µL before imaging. 
 For oligonucleotide hybridization assay, DNA hybridization was performed using 
4 × SSC- sodium dodecyl sulfate (SDS) (1X SSC: 0.15 M sodium chloride and 0.015 M 
sodium citrate, pH 7.0) for 30 min at 42°C. Care was taken not to exceed this 
temperature as QD coating is not stable at temperatures greater than 46°C for prolonged 
periods.  
Data Acquisition and Analysis 
 All images were taken using an Olympus IX-71 microscope (Center Valley, PA) 
that was equipped with a mercury lamp for excitation, a Nikon D70 color digital camera, 
and a 100 x objective (NA 1.25, oil). The hybridized or control sample (1-3 µL) was 
spread between two clean cover slips (no. 1 coverglass, Corning Inc., Corning, NY) and 
was placed on an epi-fluorescence microscope. True color fluorescence images were 
obtained by using 488-nm excitation and a long pass filter (505 nm, Chroma Technology 
Corp., Brattleboro, VT). The exposure times were 0.2-2 seconds. The fluorescence 
spectra of the QDs and the fluospheres (excitation = 505 nm, emission = 515 nm; 
Invitrogen Inc.) were recorded by using a standard fluorometer (FluoMax; Jobin Yvon, 
Edison, NJ), and the spectra of single MMPs were recorded by using a 
spectrophotometer (SpectraPro 150, Roper Scientific, Trenton, NJ) attached to the side 
port of the microscope. All images were analyzed by using NIH Image J software [22]. 
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4.3 Results and Discussion  
 The basic principle of the single-bead sandwich assay is shown in Figure 4.1. In 
this procedure, antibody-conjugated magnetic microbeads capture target molecules 
(DNA or protein) from solution by binding them either through antigen-antibody 
recognition or oligonucleotide hybridization. For DNA fragment isolation, oligonucleotides 
are conjugated to the beads (see Figure 4.5). The beads are then separated using a 
permanent magnet and subjected to several washing steps to remove non-target 
molecules. Luminescent nanoparticles (LNP) with recognition molecules specific to a 
different epitope or sequence on the target bind and “sandwich” the captured targets. 
Following a second washing step to remove unbound LNPs, beads are then imaged 
under a microscope by placing them on a thin glass coverslip. Target concentration is 
quantified based on the intensity of the integrated fluorescence signal from LNPs on 
each bead. This integrated intensity is then acquired from several beads and the values 
are averaged. It must be noted that unlike other assays in which targets are directly 
tagged, this two step assay removes the need to perform direct target tagging, which 
can be a time-consuming and highly inefficient when target concentrations are low. 
Further, the ability to manipulate samples with a magnet makes it possible to perform 
assays with minimum sample handling and contamination. For this study, we detected 
TNF-alpha since it is secreted by immune cells in response to inflammatory responses 




Figure 4.1: Schematic illustration of bead-based sandwich immunoassay using magnetic 
beads (MMP) and luminescent nanoparticles (LNP). (A) MMPs are added to a solution 
containing target molecules (protein shown here). Upon target enrichment, LNPs are added and 
bind to the target molecules captured on the bead. (B) Conjugation strategies used to couple 
recognition biomolecules to MMPs and LNPs.  
 
Another advantage of this assay is the ability to perform washing steps to increase 
specificity and reduce non-specific binding of target or fluorescent probe to the bead. 
 Initially, our imaging setup and detection sensitivity was tested using dye-labeled 
biotin (tetramethyl-rhodamine conjugated to biotinylated dextran molecule) as a reporter 
probe. High-resolution single-bead images were captured at decreasing concentrations 
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of the probe. The average integrated intensity from several beads at each probe 
concentration was obtained and is shown in Figure 4.2.  
 
Figure 4.2: Single-bead assay and fluorescence detection as a function of TMR-labeled 
probe concentration. (A) High resolution single-bead fluorescence images at varying 
concentrations of TMR dye. (B) Plot of average bead fluorescence intensity versus TMR-dextran-
biotin concentration (n=5). 
  
From the results, it is clear that although one can detect 10 pM probe concentration, 
below 1 pM the fluorescence signal from beads was not detected and was similar to that 
of bare beads. This observation was attributed to the probe signal (emission peak ~590 
nm) being buried under the visible autofluorescence from the beads.  
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 In order to determine the best probes for labeling captured targets on the bead, it 
was important to obtain the autofluorescence spectrum of bare magnetic beads 
(streptavidin-beads without any dye on surface) when excited under blue light (excitation 
wavelength = 488 nm). 
 
Figure 4.3: Autofluorescence spectrum of beads juxtaposed with fluorescence spectra of 
luminescent nanoparticles. QD525 and Fluosphere515 were used due to less overlap with 
bead autofluorescence peak. 
  
  In addition, we obtained fluorescence spectra of three nanoparticle probes, 
QD605, QD525 and Fluospheres emitting at 515 nm. From the spectra (Figure 4.3), it is 
clear that the broad bead autofluorescence spectrum tapers sharply at shorter 
wavelengths (around 510 nm) and more gently at longer wavelengths (in the near-
infrared region). Both QD525 and 515 nm emitting fluospheres do not overlap with bead 
autofluorescence as much as QD605. It should be noted that TMR dye that was used to 
obtain data shown earlier (see Figure 4.2) has a broad non-symmetric emission peak 
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with a maxima at 590 nm. This peak strongly overlaps with the autofluorescence peaks 
and further confirms the low detection sensitivity observed due to signal being buried 
under bead autofluorescence. An interesting property of QDs is that unlike dye 
molecules, they exhibit a large Stokes’ shift, whereby single light sources (such as blue 
light) can excite QDs emitting multiple colors. This unique property makes it possible to 
design probes so that they are “spectrally-shifted” from the autofluorescence of materials 
such as polymer magnetic beads. 
 Although, the autofluorescence peak also tapers in the near-infrared (near-IR) 
region, we did not evaluate near-IR probes for the following reasons. There is lesser 
availability of near-IR nanoparticle probes compared to that in the visible region. Second, 
commonly used and affordable CCD cameras and detectors are more efficient in the 
visible region compared to near-IR CCD detectors. Therefore, the LNPs we decided to 
use for our studies were either QD525 or TransFluospheres (dye-doped polystyrene 
nanoparticles) that emit at 515 nm. Dye-embedded Fluospheres are 43 nm in size and 
also bright like QDs. They also resist photobleaching to a greater extent than standard 
organic fluorophores and are excellent alternatives to QDs.  
 Next, the assay was tested by adding varying concentrations of TNF-alpha as the 
target molecule. Beads coupled-with anti-TNF-alpha antibodies (Figure 4.1) were used 
to capture the target molecules. This was followed by the addition of antibody-labeled 
green emitting Fluosphere to the sample volume. Both antibodies coupled to beads and 
Fluospheres were monoclonal but targeted to different epitopes on TNF-alpha target 
molecule. Figure 4.4 shows the results we obtained.  
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Figure 4.4: Single-bead immunoassay for TNF-alpha detection using luminescent 
nanoparticles (dye-doped particles). Fluorescence microscope images (top figure) obtained at 
varying concentrations of target. Plot of the integrated fluorescence intensity as a function of 
target concentration (bottom figure). Spectral shift of nanoparticles from bead autofluorescence is 
evident. 
 
 Upon using spectrally-shifted LNPs, a dramatic increase in detection sensitivity 
was observed. Compared to TMR-labeled probes where the detection limit was in the 
picomolar range, we see a 2-3 order of magnitude increase in detection sensitivity. This 
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is clearly evident from the green-signal visible in the single-bead fluorescence 
microscope images obtained at 6 fM target concentration (Figure 4.4, top figure). When 
comparing integrated fluorescence intensity to the background signal (shown by dotted 
line in Figure 4.4), signal was detected at the femtomolar range. Controls for this 
experiment consisted of plain beads, bead-antibody conjugates with no target present, 
and beads without any antibodies. No signal was detected from the controls.  
DNA detection 
 
Figure 4.5: Schematic illustration of methods for oligonucleotide detection.  
 
 Detecting DNA molecules from bodily fluids by using a similar bead-based assay 
holds promise for performing multiplexed genotyping and diagnosis of diseases at an 
early stage. In theory, a similar bead-based assay can be used to detect fragments in 
solution through hybridization of complimentary DNA strands. Using streptavidin-coated 
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beads and the same basic principles as discussed for protein detection, we performed a 
DNA detection assay (Figure 4.5). Unlike TNF-alpha immunoassay described 
previously, oligonucleotide having a sequence complimentary to the target sequence 
was directly labeled using QD525. The QD:DNA molar ratio at the time of conjugation 
was 1:5. 
 
Figure 4.6: Single-bead imaging and quantitative analysis of fluorescence signal obtained 
by detecting QD-labeled oligonucleotides. 
 
 This ratio was estimated because conjugation reactions are seldom 100% 
efficient. Assuming an efficiency of 50%, the final conjugation ratio would be ca. 1:2, 
therefore this ratio was chosen. Results of the assay are shown in Figure 4.6. From 
single-bead microscope images, we were able to detect a signal at 200 pM target 
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concentration. However, below this concentration no signal was detected. The integrated 
bead signal was obtained and is plotted as a function of concentration. When comparing 
DNA detection assay results with protein detection assay results, it should be 
remembered that the recognition molecules used to capture targets are entirely different 
in size, charge, function, and affinity. DNA oligonucleotide coupled to the bead was a 25 
bp sequence with a 16-carbon spacer on the terminal end. Hybridization conditions are 
generally tuned towards a particular assay but typically involve varying salt concentration 
and temperature of hybridization [23]. However, steric inhibition may prevent 
hybridization. Compared to micron sized bead surface, the oligo sequence is only a few 
nanometers. A possible solution to this problem is to introduce PEG spacer with a 
functional group at one end so that oligonucleotide can be conjugated.  
 It should be noted that a sandwich assay for DNA detection was performed in a 
similar fashion to immuno-sandwich assay described in this chapter, but despite several 
attempts under several conditions, the experiments were unsuccessful. A significant 
challenge was obtaining the right conditions for DNA triplex-hybridization, where target 
sequence is hybridized to two sequences complimentary to each half of the target. Each 
of these two sequences were conjugated to the bead and LNP. Future studies and 
solutions to address this problem are discussed in Chapter 7. 
 In conclusion, we have demonstrated a bead-based sandwich assay using 
magnetic beads and luminescent QD and dye-doped nanoparticles as probes. Further, 
we have shown that using spectral-shifting properties of QDs it is possible to by-pass 
issues of autofluorescence from beads and also from biological media where such tests 
may be applicable. This technology has potential in automated biomolecule screening in 
labs where high detection sensitivity is required. Combined with encoding technology 
discussed in Chapter 3, we believe that bead-based immunoassays using QDs as bright 
fluorescent probes can improve current detection limits obtained from ELISAs.  
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SELECTIVE CAPTURE AND MULTICOLOR PROFILING OF RARE 
CIRCULATING TUMOR CELLS USING MAGNETIC 
NANOPARTICLES AND QUANTUM DOTS 
 
5.1 Introduction 
 Metastasis is the major cause of cancer-related deaths and involves the 
dissemination of tumor cells from a primary tumor to different organs of the body[1]. 
Upon diagnosis and resection of a primary tumor, the oncologist’s decision to administer 
follow-up treatment is usually dependent on whether the disease has spread or 
metastasized to other organs in the body. This is because metastatic tumor cells are 
considered to be the source of disease relapse after surgery[2]. The most efficient way 
for the cells to spread is through the blood and lymph circulatory systems. As these 
circulating tumor cells (CTC) disseminate, most are detected as aberrant and destroyed 
by the immune system, however, a small fraction can evade these regulatory 
mechanisms and proliferate at a distant site. Not all of these disseminated tumor cells 
will develop into distant tumors. In fact, there is new evidence that suggests that a 
significant fraction of these cells are either apoptotic (dead) or do not have stem cell like 
properties [3]. By capturing and scrutinizing these cells before they metastasize, one can 
obtain a real-time cellular biopsy of the tumor without using invasive needle biopsy 
techniques. Therefore, there is a need to identify and characterize tumor cells ex vivo for 
viability, aggressiveness, and invasive potential. With a better understanding of the 
nature of disseminated cells it is possible to improve disease staging and administer 
tailored therapy for cancer patients.  
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 Even though MRI, computed tomography, and serum protein MALDI-TOF 
analysis can be used to detect residual disease, the presence of circulating tumor cells 
has been shown to correlate most sensitively with cancer progression, metastasis and 
overall patient survival [4, 5]. Detection of CTC’s from peripheral blood in patients with 
localized and metastatic breast cancer is associated with poor outcome [4-6]. In a 
seminal study by Cristofanilli et al.[4], peripheral blood of 177 patients with metastatic 
breast cancer was examined for the presence of CTC’s and observed that CTC’s were 
frequently detected in almost all patients. 60% had at least two CTC’s in 7.5 mL of whole 
blood, 49% had more than five and 21% had more than 50. 
 Current methods for detecting circulating tumor cells include histopathological 
staining, immunofluorescence [7, 8], RT-PCR[9], FISH[10], flow cytometry[8, 11, 12], 
and FAST (fiber-optic array scanning technology)[13, 14] . PCR-based assays have 
been used by exploiting expression of epithelial or cancer-specific genes to detect 
CTC’s. Although they provide unrivalled sensitivity, the major limiting factor is the 
illegitimate low-level transcription of tumor-associated or epithelial genes in normal 
cells[15, 16]. Quantitative RT-PCR, may be able to resolve these problems but will not 
provide information on the number of tumor cells detected, which is an important 
indicator of patient survival. Further, RT-PCR methods require destruction of cells and 
loss of morphological information, which can be valuable to validate tumor cell origin and 
metastatic potential. For example, it is known that cells with stem-cell like properties like 
self-renewal and increased mobility have distinctly different morphology to normal 
epithelial cells. Finally, it is not clear whether these methods can provide clinically 
relevant information such as treatment monitoring. Similarly, flow cytometry provides 
quantitative information about cell surface protein expression but provides no 
morphological information. FAST is technically challenging requiring carefully tuned 
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optics and requires spreading of whole blood onto 100 cm2 microscope slides, which is 
messy and a health hazard to the user when handling infected blood.  
 Phenotyping captured CTC’s has not been easy and is not a well established. 
Two methods, namely immunohistochemistry (IHC), and flow cytometry are often used 
to characterize rare cells. Although IHC stains cell surface markers, it is not quantitative. 
Further it is time consuming and highly subjective. Therefore, IHC cannot be used for 
routine screening of large number of patients. On the other hand, flow cytometry can be 
used to detect circulating tumor cells from non-cancerous cells through surface staining, 
but cannot provide morphological data. Although, one may argue about the value of 
morphological information in CTC characterization, the spatial location of proteins may 
offer clues to the cell’s invasive potential. 
 There is no doubt that the sensitivity of all these techniques can be improved by 
enriching target cells and eliminating background cell populations. The ratio of 
tumor:non-tumor cell in blood of early metastatic cancer patients is usually 1:106 for 1 
mL of blood. There are two ways to address this problem. First, there must be a 
concerted effort in developing separation technology for specifically isolating and 
characterizing target cells such that there are virtually no background blood cells. A 
second approach is to use existing techniques and develop imaging probes that can 
recognize tumor from non-tumor and eliminate or rule them out through image 
algorithms. Several approaches for CTC capture from blood have been pursued in the 
past. Normally, cell enrichment and volume reduction techniques are applied by isolating 
mononuclear cells from blood using red blood cell lysis or gradient separation 
techniques (Ficoll gradient separation). However, both of these approaches can lead to 
a loss of tumor cells either due to lysis, or due to variations in density. Cells are easily 
lost during Ficoll separation as the larger dense epithelial cells are lost in the granulocyte 
fraction.  
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 Another method used is positive selection or negative depletion of cells using 
immunomagnetic particles. In this approach, particles are labeled with monoclonal 
antibodies specific to epithelial cell surface markers such as the glycoprotein, EpCAM. 
However, due to heterogeneity of antigen expression across tumor and blood cells, there 
is a possibility of false positives. Negative hematopoietic cell depletion is also widely 
used to improve sensitivity in large sample volumes of blood. In this procedure, 
immunomagnetic beads conjugated with antibodies against pan-leukocyte CD (Clusters 
of Differentiation) markers such as CD45 are used to remove leukocytes. Unfortunately, 
this techniques does not completely remove all the non-tumor cells. The focus is on 
developing standardized technology that will enable selective capture of target cells, and 
elimination of false positives. Although, such nanoparticles have been used in the past 
for cell capture, advances in nanoparticle synthetic chemistry[17] have made it possible 
to synthesize a large batch of highly monodisperse magnetic nanoparticles [18-20]. The 
magnetic properties of the uniform nanoparticles can be tuned precisely and also enable 
more efficient biological tagging and separation.  
 There were two goals for this study; (1) to demonstrate application of QDs in 
identifying and profiling magnetically enriched tumor cells artificially spiked in blood 
using spectroscopic methods (2) to compare separation efficiency of uniform and single 
magnetic nanoparticles to larger commercial polydisperse magnetic nanoparticles in 
isolating tumor cells. Using this integrated approach, we believe it will be possible to 
monitor patient response to therapy and predict disease invasiveness. Therefore, our 
hypothesis is that a combination of immunomagnetic isolation and QD-based 
multiplexed cell protein profiling will provide quantitative and morphologically relevant 
data in establishing patient prognosis with circulating tumor cell phenotype and load. 
Here, we describe the integration of magnetic iron oxide and Quantum Dot (QD) optical 
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nanoparticles for selectively isolating and analyzing multiple biomarkers expressed 
inside and on the cells. 
5.2 Materials and Methods 
Tumor cell line culture 
Adherent breast cancer cell lines (BT-474, MCF-7 and MDA-MB-231) of epithelial 
origin were obtained from American Type Culture Collection (ATCC, Manassas, VA) and 
were used to artificially spike media and normal human blood samples. The above 
mentioned cell lines were grown in RPMI-1640 (MDA-MB-231) and Minimum Essential 
Medium (BT-474 and MCF-7). Both types of media were supplemented with 10% Fetal 
Bovine Serum (Invitrogen, Carlsbad, CA) and 1% Penicillin/Streptomycin antibiotic. Cells 
were harvested upon reaching ~80-90% confluency using 0.05% Trypsin (containing 
EDTA) (Mediatech Inc., Herndon, VA), followed by washing steps before seeding them 
into 25 cm2 culture flasks (Corning, Corning, NY) at a high seeding density. Due to the 
tendency of MCF-7 and BT-474 cells to clump, the trypsinized cells were passed through 
a 30 µm filter (BD Biosciences, San Jose, CA). In addition, two prostate cancer cell lines 
that were cultured at Emory University from ascites fluid of prostate cancer patients, 1A8 
and 1F11 were used. These cells display an epithelial-to-mesenchymal transition (EMT) 
and are morphologically and phenotypically distinct. We used these cells to demonstrate 
multicolor molecular profiling upon isolation. Similar culture procedures were used for 
these cells with T-medium (Mediatech Inc., Herndon, VA) used instead. Prior to spiking 
cells, they were counted manually by adding fixed volume of cell suspension to a 96-well 
transparent plate and recording cell number. Approximately 300-400 cells were used per 




 Normal human blood was collected using standard veni-puncture practices into 
2-3 CellSave (Immunicon Inc. Huntington Valley, PA) evacuated 10 mL glass tubes. The 
first tube containing blood was discarded to reduce contamination from skin epithelial 
cells. CellSave tubes contain disodium EDTA anti-coagulant, polyethylene glycol and a 
proprietary preservative. According to vendor documentation, the preservative is used to 
preserve morphology and cell surface antigen expression over a period of 72 hours. 
Cultured cells were then enumerated and spiked into whole blood solutions (typically 1-2 
mL) and used for further experiments. Whole blood was kept at room temperature, 
opened under sterile condition, and used immediately. 
Magnetic Nanoparticles and Microbeads  
 Magnetic particles were either obtained from a commercial vendor, Invitrogen 
Inc. (Carlsbad, CA) and Immunicon Inc. (Huntington Valley, PA) for cell isolation 
experiments. The particles from Invitrogen were CELLection Dynal Microbeads (4.5 µm 
in diameter) and are conjugated to mouse anti-EpCAM (BER-EP4 epitope) antibodies. 
The antibodies on the bead can be cleaved from the bead surface via a cleavable DNA 
linker conjugated on one end to the Fc portion of the IgG molecule and on the other end 
to the carboxylated bead surface. The nanoparticles were either pre-conjugated to 
antibodies specific to tumor cells or were pre-coated with streptavidin. In addition 
uniform magnetic nanoparticles prepared using a method developed by Yu and co-
workers [21] were provided by Ocean Nanotech Corp. (Fayeteville, AK). These 
nanoparticles were 30 nm in diameter and coated with hydrophobic ligands. In order to 
be used in biological medium, they were coated with two types of polymers to phase-
transfer into the aqueous phase, (i) poly (maleic anhydride co-alt-1-octadecene) 
amphiphilic polymer (Mn ~ 30,000-50,000) with 30% carboxyl groups coupled to PEG, 
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using modified procedure originally described by Yu et al. [22], and a (ii) poly(acrylic 
acid, tetradecene modified) amphiphilic polymer (MW ~ 3,500, provided by Brad Kairdolf, 
Nie group). Concentration of hydrophobic magnetic nanoparticles was measured 
through absorbance and a standard curve provided by Ocean Nanotech. Additionally, 
amphiphilic polymer coated nanoparticles concentration was measured by Inductively 
Coupled Plasma (ICP-MS) analysis (UGA Chemical Analysis Lab, Athens, GA).  
Magnetic Tagging and Isolation 
 Cells grown in culture were detached using 0.05% Trypsin. After manual 
counting, a fixed number of cells were spiked either into normal human blood or cell 
culture media. The spiked blood was centrifuged at 800xg for 10 minutes to remove 
interfering serum proteins. 25 ul of 100 ug/mL biotin-EpCAM IgG (R&D Systems, 
Minneapolis, MN) was added per 500 ul of blood solution. After incubating this solution 
at 4°C for 30 minutes, (to prevent endocytosis of IgG molecules) 35 ul of streptavidin-
coated magnetic nanoparticles was added and the solution was incubated at room 
temperature for 60 minutes. Afterwards, the magnetically-labeled cells were isolated by 
placing the sample on a permanent magnet (NdBFe 1.5T, MCE, Torrance, CA) and 
washed three times with PBS (Phosphate Buffered Saline, 10 mM, pH 7.4) buffer 
containing 0.1% BSA (Bovine Serum Albumin). The cell solution was either transferred 
manually to superfrost microscope slides, or spun down using a cytospin device.  
When using Dynal microbeads pre-coated with anti-EpCAM antibodies, beads 
were first incubated with cell suspension for 30 minutes at 4C to minimize phagocytosis 
or uptake by cells. Following washing steps with PBS containing 0.1% BSA, the tagged 
cells were then transferred into RPMI-1640 medium  
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Cell transfer to microscope slides 
 Cell suspension was transferred onto Superfrost slides (Fisher Scientific, 
Waltham, MA) using a Cytospin 3 cytocentrifuge machine (Thermo Shandon, Waltham, 
MA) for 6 minutes at 700 rpm using medium acceleration. The superfrost slides are 
specially coated slides so that cells adhere to the surface electrostatically. Also, there is 
reduced background fluorescence. The cytocentrifuge speed was determined after 
testing cytospun slides at various speeds for nuclear integrity. At speeds above 800 rpm, 
cell shearing and nuclear disintegration was visible. We also observed that when cells 
tagged with magnetic nanoparticles were cytospun, the cells were shredded and the 
plasma membrane and nuclear membrane were severely disrupted. This may be 
because the highly dense nanoparticles are strongly influenced by the centrifugal forces. 
When cells were isolated using magnetic nanoparticles, cell suspensions were 
transferred manually onto the slide, which was placed on a permanent magnet 
customized to fit 4 slides in parallel on it. The slides on magnet were kept at 4°C for 1 
hour until cells had settled onto the slide. Washes using PBS Buffer (10 mM, pH 7.4) 
were performed with great care and while making sure that the slides were firmly 
secured to the magnet.  
Cell staining using Quantum Dots 
 After transferring the cells on to the microscope slides, they were fixed and 
permeabilized for 20 minutes using a mixture of 3.7% formaldehyde and 0.1% Triton X-
100 surfactant in 10mM PBS (pH 7.4), followed by washing with PBS. A blocking buffer 
(Goat serum + BSA) was added to prevent non-specific protein binding. Subsequently, 
antibodies specific to antigens of choice were added either simultaneously or in 
sequence. The concentration of antibody varied between 5-10 ug/mL. For breast cancer 
profiling, antibodies against ER (Estrogen Receptor), HER2, PR (Progesterone 
Receptor), CD45 (for staining white blood cells) were used, whereas anti-Vimentin and 
anti-E-Cadherin antibodies were used for prostate cancer cell profiling. Upon incubating 
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the antibodies for 2 hours at room temperature, excess antibodies were washed from 
samples, and 20 nM of QD-secondary antibody conjugates (Invitrogen, Carlsbad, CA) 
were added. These QDs are coated with antibodies specific to the species in which the 
above four were raised. As some are raised in the same animal, the QDs are added in 
sequence with a washing step in between to remove excess unbound QDs. The QD 
staining step can either be done at room temperature for 2 hours or overnight at 4°C. 
Finally, the samples were counterstained with DAPI (4',6-diamidino-2-phenylindole) a 
nuclear staining dye and mounted for long term storage. 
Single-cell spectroscopy and imaging 
 Molecular profile and relative abundance of stained protein markers were 
obtained using a spectrometer (Acton SP-150, Acton Research, Acton, MA) fitted to the 
side port of a epifluorescent microscope (Olympus IX-70, Olympus, Center Valley, PA). 
Exposure times for the acquisition of spectra ranged from 0.1-1 s. Images were acquired 
using a CCD camera (Olympus, Center Valley, PA) and a 20x PlanApo or 100x oil (NA 
1.3)  immersion objective (Olympus, Center Valley, PA). The true color fluorescence 
images were obtained using a 460-490 nm band pass excitation filter and a 505 nm long 
pass filter (Chroma Tech. Brattleboro, VT). The exposure times varied from 0.2- 4 
seconds.  
5.3 Results and Discussion 
Magnetic Separation 
 Epithelial cells strongly express Epithelial Cell Adhesion Molecules (EpCAM) 
glycoprotein on their surface. Since the vast majority of metastasized cancer cells in 
peripheral blood are epithelial in origin [23], we decided to use anti-EpCAM antibody 
coated magnetic particles for our experiments. Most commercial kits also provide 
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EpCAM antibody conjugated nanoparticles/microparticles for epithelial cell enrichment. 
The general enrichment strategy (Figure 5.1) is very easy, relatively quick (depending 
on magnetic nanoparticle size) and allows for non-target cells to be washed off and 
reduce sampling volume. Although an excess of anti-EpCAM magnetic particles can be 
added to the sample, the optimum ratio of magnetic particle to cell is dependent on the 
size of particles. Larger beads used in our studies were detached from the cell surface 
after isolation through a DNA linker between the bead and antibody that was cleavable 
using DNAse enzyme (see Methods section). When isolating artificially spiked tumor 
cells from whole blood, a range of 2 x 107 to 1 x 108 beads per mL of blood was used. 
Upon isolation, magnetically labeled cells can be transferred to microscope slides using 
cytospin centrifugation to transfer cells from solution to slide. Although this method is 
convenient, it may result in cell loss, or shearing of cells if spun down at high g forces. 
An alternative but intricate method is to manually transfer the cell suspension onto a 
positively charged microscope slide with a magnet held underneath it. This method 
works with higher cell transfer efficiency but is tedious and error-prone. Since our main 
focus was to reduce total CTC cell loss, we decided to use cytospin when dealing with 
more than 200 cells per sample, and the manual method was used for lower 
concentrations.  
 After cell transfer is complete, QDs are stained using an indirect immunostaining 
procedure commonly used for staining cells with dye-conjugated antibodies. In this 
procedure, primary antibodies produced in various species bind to targeted antigens 





Figure 5.1: Schematic illustration of tumor cell isolation and profiling using magnetic 
nanoparticles and QDs. 
 
 QDs conjugated with antibodies raised in the same species as the primary 
antibodies are then added to the cells. Therefore, one indirectly labels the antigens 
being targeted. Finally, after counterstaining with 4',6-diamidino-2-phenylindole (DAPI), a 
nuclear staining dye, the samples are mounted and imaged under a microscope. Using 
single-cell spectroscopy methods similar to those used to obtain spectra from dual-
function encoded beads (see Materials and Methods section in Chapter 3), the spectral 
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signature of the cell can be obtained to obtain cell phenotype while preserving 
morphology and other spatial information from the cell. 
Isolation and Profiling of Morphologically and Phenotypically Distinct Prostate 
Cancer Cells 
 To determine whether cells artificially spiked in blood could be enriched and 
profiled for molecular expression, Prostate cancer cell lines that showed an epithelial-to-
mesenchymal transition (EMT) were chosen. Epithelial cells are restricted in their ability 
to grow outside their normal environment. For an epithelial cell tumor to metastasize, the 
cellular signaling pathways must undergo dramatic changes that permit cell survival and 
proliferation at non-physiological locations[23]. Initiation of metastasis in primary tumors 
requires loss of cell adhesion through repression of certain adhesion molecules, such as 
E-Cadherin. For epithelial cells to become metastatic, they must change their 
morphology and acquire the ability to escape the control of these survival signals, that is, 
undergo an EMT (Epithelial-Mesenchymal Transition)[24, 25]. 
 Also, these cells are known to acquire increased mobility, so that upon 
dissemination, they can invade into distant organs and proliferate. This change in 
phenotype is typical of EMT where cells acquire “stem-cell like” characteristics. Before 
proceeding to blood-based studies, two cell lines, 1F11 (epithelial phenotype) and 1A8 
(mesenchymal phenotype) were spiked into culture medium, isolated and stained with 
QDs emitting at 525 nm and 655 nm (Figure 5.2). Two proteins were stained, E-
Cadherin and Vimentin. Vimentin is an intermediate filament and is closely associated 
with the cytoskeleton. More importantly, it was chosen as it is a commonly used marker 




Figure 5.2: Molecular profile and true color fluorescence image of prostate cancer cells 
that have undergone EMT using QD525 (Vimentin) and QD655 (E-Cadherin). (A) Mean 
fluorescence spectra (n=10) and microscopy of 1F11 (Epithelial phenotype) cells isolated and 
stained (B) Mean fluorescence spectra (n=10) and microscopy of 1A8 (mesenchymal phenotype) 
cells isolated and stained. (C) Mixed sample containing both 1F11 and 1A8. DAPI counterstain 
shown in blue. 
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 As expected, we were able to isolate and obtain molecular spectral signature of 
cells enriched from the media. 1F11 cells showed high expression of E-Cadherin and 
moderate expression of Vimentin, whereas 1A8 cells showed increased Vimentin 
expression with a down regulation of E-cadherin. The difference in molecular profiles is 
clear when juxtaposed with each other (Figure 5.2C spectra) for a mixed sample of 
1F11 and 1A8 cells. The isolation efficiency for this test was 56% on average, which is 
quite low. There are two reasons that may explain the poor efficiency. First, since 
magnetic microbeads with cleavable DNA linker was used, the efficiency of the DNAse 
enzyme will strongly determine cell isolation efficiency. This is because after cleaving 
beads from the cells, a magnet is used to remove beads and allow the cell solution to be 
transferred for further use. However, if the bead release is unsuccessful or partially 
successful, it will result in loss of isolated cells. Large micron-sized beads have such a 
great magnetic sedimentation velocity that it permits rapid cell isolation even if only one 
bead binds to the cell. Based on microscopy of cells prior to bead release, several beads 
(10-20) will bind to one cell. As a result, incomplete cleavage of the DNA linker between 
beads and antibody will result in loss of cells.  
Isolation of Tumor Cells from Blood using Magnetic beads 
 Subsequently, the same Prostate cancer cells (1F11 and 1A8) were spiked into 
whole blood and isolated (Figure 5.3). From the figure, it is clear that although tumor 
cells were detected there was interference from leukocytes. The inability to completely 
remove leukocytes after immunomagnetic cell isolation from whole blood has also been 
reported by others [27, 28]. Typically, normal human blood contains between 5,000 to 
10,000 white blood cells (WBC) per ul of whole blood. Studies were performed with 1mL 
of blood, which would contain somewhere between 5-10 million WBC’s. For this 
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particular study, the number of cells varied between 521±39 (1F11) and 588±36 (1A8) 
cells per sample.  
 
 
Figure 5.3: Multicolor QD imaging and spectral analysis of 1F11 (epithelial phenotype) and 
1A8 cells (mesenchymal phenotype) isolated from whole blood and stained with QD525 
(Vimentin) and QD655 (E-Cadherin). 
  
 This means that the ratio of WBC:tumor cell is roughly 10,000:1. There are two 
possible scenarios that would explain the presence of leukocytes. First, there is non-
specific interaction between the bead and WBCs. Second, the shear number of cells 
would make it difficult to completely remove all cells even after 4 rounds of washing with 
buffer. Images showing beads non-specifically bound to polymorphonuclear cells 
(PBMC) would suggest that the former scenario is responsible for presence of 
leukocytes. Interestingly, the spectral signature or pattern of leukocytes is different from 

















involve identifying non-tumor cells from their spectral profiles and subtracting them from 
the image using image processing algorithms. 
 
 
Figure 5.4: Spectral profile and fluorescence image of non-specifically isolated leukocytes. 
 
Isolation of Tumor Cells using Magnetic nanoparticles 
 An alternative to magnetic microbeads is magnetic nanoparticles. Unlike 
microbeads that consist of a polymer matrix containing several nanoparticles packed into 
the core, nanoparticles that were used for the next studies were 200 nm diameter 
polystyrene particles containing 20-30 iron oxide magnetic nanocrystals. The rationale 
for testing them was that having many smaller particles binding with the cell would allow 
better control over leukocyte presence upon isolation (see Background, Chapter 2). The 
assumption was that the anti-EpCAM IgG conjugated magnetic nanoparticles would bind 
to more tumor cells than leukocytes, and would allow discrimination between strongly 
labeled cells and weakly-labeled leukocytes. However, upon isolation and staining, the 
results showed a greater presence of leukocytes (Figure 5.5). Looking at the DAPI and 
QD fluorescence images, the prostate cancer cell (1A8) can be clearly distinguished due 









concerning. In fact, leukocyte population was so overwhelming that it was difficult to 
image captured tumor cells due to overlap and in some cases cells on the microscope 
slide were in multiple layers.  
 
Figure 5.5: Fluorescence images of isolated cells stained with QD525 (Vimentin) and QD 
655 (E-Cadherin). (A) Images obtained using 20 x objective and 488 nm excitation with 505 nm 
emission filter. A single tumor cell (1A8) is visible in the center of the image. (B) DAPI channel of 
the same image. (C) Overlay of DAPI emission and QD emission.  
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Profiling of Breast Cancer Cells 
 In order to demonstrate 3-4 color multiplexed profiling of tumor cells, three 
commonly available breast cancer cell lines were chosen, MDA-MB-231, MCF-7 and BT-
474. Treatment decisions in breast cancer are commonly made based on the expression 
of three target proteins, namely estrogen receptor (ER), progesterone receptor (PR) and 
HER2/neu (HER2).  ER and PR expression clearly predict for benefit from endocrine 
therapy while HER2 expression is a prerequisite for response to trastuzumab [29, 30].  
 
Figure 5.6: Molecular Profile and fluorescence image of isolated MCF-7 cells. Also included 
is the profile from leukocytes non-specifically labeled with the same QDs (n=5). (A) Bright field 
image clearly shows magnetic nanoparticles (brown color) (B) Fluorescence image of MCF-7 
cells (C) Image of non-specifically captured leukocytes. 60x oil immersion objective used. 
 
These three cells differentially express or lack the three mentioned biomarkers, and 
were labeled after isolation from whole blood.  Additionally, a pan-leukocyte extracellular 
marker (CD45) was used as a positive marker for all types of leukocytes.  
 Unlike the microbead isolation procedure, cytospin was not used to transfer cells 
to glass slides as there was shredding of the cell and loss of morphology even at 
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reasonable rcf values (300 x g). The surface of magnetic nanoparticles was coated with 
streptavidin, a glycoprotein that has a strong affinity for biotin.  
 
 
Figure 5.7: Molecular Profile and fluorescence image of isolated BT-474 breast tumor cells. 
Also included is the spectral profile of leukocytes after isolation from human blood. (n=3) 
 
 Biotinylated anti-EpCAM antibodies were incubated with the sample, followed by 
addition of the streptavidin-nanoparticles. Consistent to previous findings, leukocytes 
were ubiquitous on all slides that were prepared. Negative isolation steps are 
occasionally used to remove leukocytes, but due to addition of several extra steps and 
increase in duration of assay, no merit was seen in this. The distinct spectral signatures 
of MCF-7 cells and leukocytes were used to differentiate the two as seen in Figure 5.6. 
MCF-7 cells strongly express ER compared to HER2 and PR, and we see the same in 
the spectra. Also evident in the bright-field image (Figure 5.6A) is the inability to see the 
cell outline due to dense layer of magnetic nanoparticles (brown color due to strong 
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absorption of light). Likewise, BT-474 cells were profiled and it was possible to identify 
tumor cells and differentiate them from leukocytes (Figure 5.7). BT-474 cells overly 
express HER2 with weaker expression of ER and PR as can be seen from the spectra.  
Comparison of non-specific binding of leukocytes by magnetic nanoparticles 
 In order to address the issue of non-specific association and capture of magnetic 
nanoparticles to leukocytes we mixed equal concentration of three types of magnetic 
nanoparticles with equal volume of whole blood. These three types were (a) Immunicon 
Inc. nanoparticles that are 150 nm in diameter and are streptavidin-coated (b) PAA-TDA 
(Poly(acrylic acid)-tetradecylamine) coated magnetic nanoparticles that are 30 nm in 
diameter, and (c) PMAO-PEG (Poly(maleic anhydride-alt-1-octadecene) –PEG) coated 
30 nm magnetic nanoparticles. It is known that PEG groups sterically stabilize 
nanoparticles and prevent non-specific uptake. Upon magnetic sedimentation and 
several washing steps under magnetic field, the samples were cytocentrifuged onto 
microscope slides, counterstained with DAPI and imaged (Figure 5.8). From the results, 
we observe that both streptavidin coated nanoparticles (Immunicon) and carboxylated 
nanoparticles (PAA-OA coated) were strongly associated with leukocytes, as is evident 
from the large presence of cells with DAPI-stained nuclei (Figure 5.8 A & B). Non-




Figure 5.8: DAPI fluorescence images of leukocytes non-specifically captured. (A) 
Immunicon 150 nm magnetic nanoparticles (B) 30 nm polyacrylic acid coated magnetic 

















73% 56% 78% 
Table 5.1. Comparison of cell separation efficiencies. Average cell count obtained from 
triplicates  (n=3). MCF-7 cells (EpCAM positive) captured from culture media. 
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 During isolation, we recorded the separation efficiencies (Table 5.1) for each of 
the magnetic separation. Compared to the microbead separation procedure, both 
nanoparticles, although different in size were comparable in separation efficiency. We 
can also conclude from the values that even though the efficiency of the 30 nm particles 
is fractionally better, such nanoparticles hold greater promise for post-capture multi-
spectral analysis using QDs since they are smaller than the larger Immunicon 
nanoparticles. Invariably, one is going to face a situation where larger nanoparticles 
allow faster separation, but may not be ideal for one’s application. It should be noted that 
these efficiency values were obtained from 1 cell line and by isolating them from culture 
medium. Further studies need to determine this efficiency across a number of epithelial 
tumor cell lines having varying expression of EpCAM. Also, studies should determine 
isolation efficiency from whole blood samples. It is hoped that this initial work will provide 
the foundation for further improvements in cell separation.  
 In conclusion, we have demonstrated multicolor QD spectral profiling of 
magnetically isolated tumor cells. Prostate cancer cells with distinctly different 
morphologies and protein expression levels were isolated with magnetic microbeads and 
labeled with QDs successfully. However, isolation of cells in blood posed a technical 
challenge due to the overwhelming number of leukocytes. We tried to address this issue 
by distinguishing tumor cells from leukocytes by obtaining fluorescence spectral profiles 
and showed that this could be done. In some cases we observed that number of 
leukocytes was so great that they were physically obstructing tumor cells and prevented 
spectral profiling. To address leukocyte non-specific binding, we have recently 
developed PEGylated polymer coatings that drastically reduce this problem. Hpwever, 
further tests need to be performed after conjugation to EpCAM antibody, as illegitimate 
expression of small amounts of EpCAM on leukocytes may still prevent elimination of 
leukocytes after magnetic isolation.  
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 In the following chapter, we attempt to understand nanoparticle-leukocyte 
interactions as a function of surface coatings using QDs instead of magnetic 
nanoparticles. This is because the superior fluorescent properties of QDs permit imaging 
and fluorescence-based quantitative assays to examine nanoparticle behavior in blood.  
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CHAPTER 6 
EXAMINING THE BEHAVIOR OF QUANTUM DOTS IN HUMAN 
BLOOD AS A FUNCTION OF SURFACE COATINGS 
 
6.1 Introduction 
 In the previous chapter we observed non-specific association of magnetic 
nanoparticles with leukocytes. In order to understand these interactions and the types of 
cells involved we used QDs to study nanoparticle behavior in whole blood as a function 
of surface coatings. The emergence of Quantum Dot nanocrystals (QD) [1, 2] as an 
alternative to traditional fluorescent dyes has seen a tremendous rise in biomedical 
applications such as single-molecule imaging[3], in vivo imaging [4], live cell imaging [5, 
6] and cell and tissue labeling[7]. Much of this rise can be attributed to the QD’s distinct 
and robust size-tunable optical properties that are only seen in the nano-scale size 
regime [8-11]. From a structural perspective, QDs and similar-sized nanomaterials are in 
the same size scale as biological molecules and therefore a small number of 
nanoparticles can interact with many proteins due to the large surface-to-volume ratio. 
With this increased interaction comes growing concern about nanoparticle toxicity, 
biodistribution, and blood circulation half-life[12-14]. Even though there have been 
promising developments in the application of QD probes for in vivo targeting and 
imaging[4, 15], the behavior of QDs and other nanoparticles in human blood where there 
is first contact with soluble proteins and immune cells is not well understood.  
 Depending on surface properties, such as charge and hydrophobicity, 
nanoparticles have been shown to be coated by proteins (opsonins) within a few 
minutes. It is thought that the nature of this protein adsorption (opsonization) will 
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ultimately decide the fate of the nanoparticles, causing removal from circulation by 
mononuclear phagocyte system (MPS) and polymorphonuclear phagocytes[16]. A 
recent study by Cedervalli et al.[17] indicates that the initial adsorption of proteins, which 
depends on the surface chemistry, shape and size of nanoparticles, results in a corona 
that will determine further interactions with other proteins and cells. More generally, the 
primary forces behind protein adsorption on nanoparticles in blood are thought to be 
hydrophobic and electrostatic interactions, together with conformational changes and 
associated changes in entropy in adsorbed proteins.[18-20] Plasma proteins implicated 
in the clearance of nanoparticles have been shown to include, fibronectins, complement 
(C3), albumin, fibrinogen, IgG, immunoglobulin light chains and apolipoproteins (Apo A-I 
and ApoE).[12, 16, 21-23]. 
 Developments in biomaterials for biocompatible non-fouling medical devices 
have led to emergence of PEG (polyethylene glycol) and polysaccharide-grafted 
nanomaterials. These nanoparticles resist protein adsorption and significantly improve 
circulation half-life through a steric repulsion effect [24, 25]. PEG, in particular has 
become popular as it is hydrophilic, non-immunogenic and enables straight-forward 
conjugation chemistry[26]. A detailed study by Luck et al. discussed possible 
correlations between physicochemical characteristics and protein adsorption and 
showed that particles with neutral hydroxyl groups had ten times lower protein 
adsorption compared to charged particles.  
 In this chapter, we have examined interactions of three types of QD surface 
coatings with three different types of leukocytes (granulocytes, monocytes, and 
lymphocytes) in the presence and absence of plasma proteins. The three QD surface 
coatings in order of decreasing negative zeta-potential are QD-COOH (a highly anionic 
surface coating); QD-OH (anionic surface coating modified with propane-diols to yield 
hydroxyl groups) and QD-PEG-Micelle (a dense micellar encapsulation of QDs with 
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amphiphilic PEO-PMMA). In order to quantify association of these QDs with the three 
cell types, we performed flow cytometric measurements. Further, protein adsorption 
studies were conducted using gel shift assays. Single-cell fluorescence microscopy was 
performed to study the non-specific binding, uptake and spatial localization of QDs. 
Time-dependent studies on the association of QDs with cells are also reported. We 
report for the first time, the application of QDs to study the interactions of nanoparticles 
with three types of immune cells as a function of nanoparticle surface properties. These 
findings will enable a new generation of nanoparticles and nanodrug formulations for in 
vivo imaging and targeted delivery of therapeutic agents. Additionally, we hope these 
results will also lead to the development of non-interacting nanoparticles for assays such 
as magnetic capture of rare cells from human blood. 
6.2 Materials and Methods 
Nanoparticle coatings  
 Monodisperse, fluorescent red-emitting CdSe/ZnS core-shell Quantum Dots 
(emission peak = 633 nm) coated with organic ligands were synthesized using 
established procedures [27] and purified by precipitation and re-dispersion in Acetone 
(Sigma-Aldrich) and Hexane (Sigma-Aldrich) respectively. The nanoparticles were made 
water soluble by self-assembly of an amphiphilic polymer on the nanoparticle surface. 
Two types of polymers were used for surface coating, (i) a polyacrylic acid polymer (MW 
3500) modified with tetradecylamine, (PAA-TDA) and (ii) a poly(methyl methacrylic acid) 
polymer backbone with poly(ethylene oxide) grafted (PMMA-PEO). Upon self-assembly 
and phase transfer the hydrophilic carboxylic acid groups in PAA-TDA are exposed to 
the aqueous environment, whereas the long-carbon alkyl chains (TDA) interact strongly 
with hydrophobic surface ligands on the QD surface. Similarly, the amphiphilic PMMA-
PEG block copolymer encapsulates the nanoparticle to form a micelle-like structure. 
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Hydroxyl-modified QDs (QD-OH) were prepared by conjugating 2-amino 1, 3-
propanediol (Acros, Morris Plains, NJ) to the PAA-TDA coated QDs using EDC (1-ethyl-
3-(3-dimethylaminopropyl) carbodiimide hydrochloride, Pierce Biotech, Rockford, IL) 
coupling procedures[28]. Hydrodynamic size of all three types of nanoparticles was 
determined using a Dynamic Light Scattering (DLS) machine (Brookhaven 90Plus, 
Worcestershire, UK). Zeta potential measurements were obtained using a Zetasizer 
instrument (Zetasizer Nano ZS90, Malvern Instruments, Worcestershire, UK). 
Blood Collection and FACS  
 Healthy donor blood was obtained through standard venipuncture technique 
using 20-gauge needle (BD Medical, Franklin Lakes) and 10 mL CellSave vacutainer 
collection tubes (Immunicon Inc., Huntington Valley, PA) containing anti-coagulant 
disodium EDTA. Blood samples were stored at room temperature until use. It should be 
noted that all experiments were performed on fresh blood (no longer than 2 hours post-
collection) to ensure maximum blood cell viability and minimum perturbations to the 
cells. Leukocytes in the whole blood were labeled with dye-conjugated antibodies 
(Biolegend) targeted to CD ligands specific to granulocytes (FITC-anti-CD66b), 
monocytes/macrophages (PE-anti-CD14) and lymphocytes (APC-anti-CD5) for 20-30 
minutes in the dark at 4°C. A 5:1 (v/v) ratio of 1x RBC Lysis Buffer (Ebiosciences, San 
Diego, CA) to blood to selectively lyse RBC’s. After adding the lysis buffer, blood sample 
was kept in the dark for no more than 10 minutes. Upon hemolysis, the sample was 
centrifuged at 400 x g using a swinging-bucket rotor for 7-10 minutes, followed by 
removal of supernatant and re-dispersion of pelleted cells in 10mM PBS (formula) 
containing 2mM EDTA. Using a BD FACSAria (BD Biosciences, San Jose CA) flow 
cytometry machine, the leukocyte suspension was sorted into three tubes containing 
granulocytes, monocytes and lymphocytes. QDs with different coatings were then 
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incubated with the cells either in the presence or absence of plasma at 4°C or 37°C. A 
488 nm blue laser excitation source together with a PE-Alexa 610 emission channel was 
used for the analysis. Quantitative analysis of QD adsorption/uptake to cells was 
performed using the same flow cytometry system, however instead of performing RBC 
(red blood cell) lysis and then incubating cells in plasma, QDs were added to whole 
blood and quantified directly with the flow cytometer. In the case where QD 
uptake/binding was examined in the absence of plasma, RBC lysis was performed as 
described above. Cell concentration was determined from cell count events obtained 
during the cell sort and by measuring the total volume of cell suspension. Plasma was 
obtained from a second vial of blood by centrifugation for 15 minutes at 5000 x g 
followed by transfer of the supernatant. Plasma used in all experiments was from the 
same batch of blood as that used for leukocyte sorting. 
Gel Mobility Shift Assay  
 Agarose gel (0.8% w/v) was prepared in 0.5 x TBE Buffer (Tris-HCl + Borate 
Buffer + EDTA, pH 8.0) and heated for 75 seconds in a microwave at maximum power 
until a clear solution was obtained. The agarose solution was cast in a refrigerator for 30 
minutes and placed into an electrophoresis tray containing 0.5 x TBE Buffer. Upon 
loading the QD samples, a voltage of 100V was applied for 1 hour. The gel was then 
imaged using a UV transillumination system (BioRad, Hercules, CA).  
Single-cell fluorescence microscopy 
  FACS (Fluorescence Assisted Cell Sorting) was performed as mentioned earlier 
to obtain the three cell types. The cells were incubated with QD samples either 
containing plasma solution or PBS Buffer. Upon incubation in certain specific conditions, 
such as 4°C or 37°C temperature, the cells were washed twice by centrifugation at 400 x 
g for 5 minutes followed by removal of the supernatant. The washes were important to 
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remove unbound QDs from the solution as they will increase background interference 
and make it difficult to image single leukocytes. Following the last washing step, the 
sample volume was reduced to increase cell concentration. To a clean No. 1 Cover 
Glass (Corning), 4 ul of cell suspension was added and gently spread uniformly in 
circular motions. The solution was not spread too thin to prevent quick drying of sample. 
Images were obtained using a 100 x oil immersion objective (NA 1.35, infinity-corrected), 
a mercury-arc lamp with bandpass excitation filter (BP460-490) and emission filter 
(510LP). Images were captured using an Olympus CCD Camera (Model, Olympus, WA) 
attached to an Olympus IX-71 inverted epifluorescence microscope. Bright field, 
fluorescence, and combination images (bright field + fluorescence) were obtained by 
varying exposure settings based on signal intensity. Prior to taking images, cell type was 
confirmed by signal from fluorescent dye attached to cell surface, i.e. in case of 
granulocytes labeled with FITC-anti CD66b antibodies, green signal confirmed positive 
cell sample. In order to make sure that certain samples (QD-OH and QD-Micelles) 
indeed didn’t have any QDs bound or internalized, fluorescence images were taken at 
high exposure times.  
Bulk fluorescence measurements 
  Uptake or non-specific adsorption of QDs to the cells was measured in bulk by a 
mass balance analysis on QDs in solution. QDs at a specific concentration (ranging from 
50 pM to 5 nM) were added to a solution of 10 mM PBS (pH 7.4) containing a fixed 
number of cells. The initial fluorescence intensity of the solution at the peak emission 
wavelength of QDs (633 nm) was measured using a PTI QuantaMaster  NIR QM5 
spectrofluorometer (PTI, Birmingham, NJ) followed by a reading after a fixed time 
interval. Both concentration-dependent and time-dependent studies were conducted in 
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this manner. The difference or loss in fluorescence intensity was calculated to 
understand dynamics of nanoparticle uptake/non-specific binding. 
6.3 Results and Discussion 
Nanoparticle-cell interactions 
 Blood is a complex and diverse biological medium containing as many as 3,700 
types of proteins[23], platelets, erythrocytes (Red Blood Cells) and leukocytes (White 
Blood Cells). The advantages of nanoparticles from a functional and physical 
perspective are now evident and applications in biological systems in vitro and in vivo 
are exponentially growing. Currently, the mechanism by which nanoparticles (10-50 nm 
in diameter) interact with cells in whole blood is not well understood. Studies focused on 
understanding them will be important not only to engineer better nanoparticles for 
imaging and therapeutic applications, but to assess their overall toxicity at a cellular and 
tissue-level.  
 Numerous reports [20, 29-35] have demonstrated the effects of surface charge 
on protein adsorption and subsequent phagocytosis. In fact, there is agreement that 
surface characteristics and size are the major factors [36] in clearance and 
biodistribution. Polycationic nanoparticles (positively charged) are toxic and 
immunogenic due to their membrane disrupting properties[37] and are generally not 
considered for in vivo/whole blood applications. Anionic nanoparticles, although less 
toxic, have been consistently shown to bind strongly to plasma proteins and are rapidly 
cleared by cells of MPS. In cultured cells, anionic nanoparticles have been observed to 
non-specifically attach to the cell membrane (Kairdolf and Nie, unpublished results). 
Preventing this non-specificity has been achieved through the attachment of high 
molecular weight ( >2000 Da) PEG chains to the nanoparticle surface. PEGylation of 
nanoparticles is known to reduce protein adsorption due to the ability of the coiled PEG 
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chains to sterically shield hydrophobic or charged groups and prevent non-covalent 
interactions. It has also been hypothesized that a cloud of water molecules around the 
PEG chains serves to repel hydrophobic groups on proteins [38]. 
 
 
Figure 6.1: Schematic illustration showing different types of QD coatings and possible 
interactions with live human leukocytes. (A) Three different types of QD polymer coatings with 
varying degrees of net surface charge. (B) Possible scenarios for QD depletion in blood by 
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leukocytes include I. Nanoparticle opsonization and phagocytosis, II. Non-specific cell membrane 
interactions and III. Fluid-phase uptake (pinocytosis) 
  
 However, the method of PEGylation, surface heterogeneity and PEG surface 
density can drastically affect protein adsorption [16, 26, 39, 40]. Further, there is a 
significant increase in nanoparticle hydrodynamic diameter (see Figure 6.2), which can 
have an adverse effect on renal clearance of nanoparticles. Therefore, there is a need to 
engineer surface coatings that exhibit PEG-like properties but without the thick 
hydrophilic shell. There are few findings that examine how less-bulky hydroxyl group (-
OH) modified nanoparticles interact with cells. Owing to the reduction in negative 
charge, we hypothesize that -OH modified QDs should prevent non-specific association 
with cells. For this purpose, we have prepared three types of nanoparticle surface 
coatings that have varying degrees of negative zeta-potentials, ranging from strongly 
anionic (QD-COOH) to near-neutral (QD-PEG-Micelle). The QD-OH nanoparticle coating 
was developed by partially modifying QD-COOH nanoparticles with an n-diol (Figure 
6.1A).  
 The cellular components in blood play a significant role in determining the half-
life of nanoparticle circulation in blood. Immune cells (leukocytes) are programmed to 
clear foreign bodies, antibody-coated particles, cell debris and other antigens in a rapid 
manner. Certain types of cells can ingest the nanoparticles or mediate or trigger an 
inflammatory response through cytokine secretion. These cells are diverse in origin, 
size, function and cellular structure and so the removal of nanoparticles by these cells 
can be described by three main mechanisms (Figure 6.1B). Phagocytosis is an actin-
dependent highly regulated energy-dependent mechanism of particle internalization and 
antigen presentation only seen in specialized cells called phagocytes[41]. Foreign 
bodies such as large pathogens and nanoparticle clusters are cleared by phagocytes 
such as macrophages and neutrophilic granulocytes by recognition of opsonins on the 
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surface through a process called opsonization. Opsonins are small plasma proteins and 
fragments that are thought to encounter nanoparticles and pathogens by Brownian 
motion and bind to nanoparticles through non-covalent interactions. These tagged 
nanoparticles are detected by professional phagocytes and internalized. Second, 
nanoparticles, coated or un-coated by opsonins, can bind to the surface of the cell 
membrane, again through non-specific weak intermolecular electrostatic and Van der 
Waal forces, a process often termed as adsorptive endocytosis [19, 41, 42]. This 
membrane-association is typically dependent on nanoparticle charge and surface 
hydrophobicities [14, 19, 20]. Third, nanoparticles can enter a cell through a process 
called pinocytosis, which involves fluid-phase uptake of the extracellular milieu. The 
degree of uptake is therefore directly proportional to the concentration of nanoparticles 
outside the cell.  
Nanoparticle characterization 
 The stability of QDs coated with –OH, -COOH and –PEG surfaces in isolated 
fresh human plasma was analyzed by measuring fluorescence signal in regular salt 
buffer (PBS) and plasma. Upon incubating QD samples in human plasma proteins for 24 
hours fluorescence spectra were obtained (Figure 6.3). The slight decrease in the peak 
intensity together with a broad band present at shorter wavelengths can be attributed to 
scattering by larger proteins and presence of weakly fluorescent protein aggregates. 
Additional tests (data not shown) were performed to determine stability of QDs after 
incubation. These included fluorescence measurements after centrifugation to determine 
protein-induced aggregation. Among the three QD coatings, QD-PEG-Micelle was most 
stable and unaggregated whereas, QD-OH and QD-COOH showed ~50% decrease in 




Figure 6.2: Hydrodynamic size of QDs with different surface coatings. (A) QD-COOH, (B) 
QD-OH and (C) QD-Micelle.  
 
Figure 6.3: Fluorescence spectra of QDs in plasma. Scattering of light by plasma proteins and 
the excitation of weakly fluorescent proteins is evident by the broad band at shorter wavelengths. 
Excitation at 488 nm.  
  
 Based, on the apparent instability of QD-COOH and QD-OH in plasma, we 
investigated protein adsorption and nanoparticle clustering by running a gel mobility shift 
assay. QD-COOH and QD-OH were clearly unstable in plasma and exhibited reduced 
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mobility due to increase in size. The same batch of QDs were visibly aggregated and 
showed no blinking under excitation, a common test to confirm presence of single 
crystalline QDs. As expected, PEGylated QDs such as the QD-Micelle nanoparticles 
were still single, stable, and fluorescent after the plasma incubations, but migrated 
slightly towards the cathode, indicating protein adsorption.  
 
Figure 6.4: Gel mobility shift assay of coated QDs in the presence of human plasma 
proteins. QD-Micelles are stable but interact with the slightly negative charged proteins causing 
migration. Both QD-COOH and QD-OH are coated by plasma proteins and show decreased 






Figure 6.5: Quantitative analysis of QD uptake by leukocytes in presence of human plasma 





Figure 6.6: Quantitative analysis of QD uptake by leukocytes in absence of human plasma 






 It is possible that irregular coverage of PEG chains and exposed hydrophobic 
PMMA polymer chains could explain this observation. Literature suggests that no 
sterically protected nanoparticle is completely inert and can interact with proteins 
through collective weak associations of Coulombic, hydrophobic and Van der Waal 
forces[16]. Additionally, it is possible that the near-neutral zeta potential and the tight 
packing of PEG groups on these QDs may screen for small sized proteins to associate 
with the surface. Results from size exclusion chromatography on the same nanoparticle 
samples (data not shown) also support these observations. 
Flow cytometry analysis 
 The three possible modes of QD-cell association have been described earlier. 
However, it must be noted that the mode of nanoparticle association or internalization in 
human blood is bound to be cell-dependent as leukocytes have different functions and 
may show dissimilar behavior with nanoparticles. Therefore, leukocyte interactions with 
QD nanoparticles were examined using flow cytometry. The extraordinarily bright 
fluorescence of QDs makes it easy to rapidly analyze and quantify nanoparticle-cell 
interactions as a function of surface coating in a high throughput manner. 
 As the three different types of leukocytes (granulocytes, monocytes, and 
lymphocytes) have varying roles in the immune system, this study also helps us 
understand cell-specific interactions and the role plasma proteins play in mediating the 
interactions. Initially, we studied interactions in the presence of plasma proteins by 
incubating QDs with whole blood containing plasma proteins. After 3 hours incubation at 
37°C, the results revealed a very selective uptake of QD-COOH by monocytes and 
macrophages (mature monocytes) cell type (Figure 5). Monocytes and macrophages 
are phagocytes and are known to ingest particles coated with proteins in a very efficient 
manner. This opsonin-mediated uptake of nanoparticles by monocytes and 
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macrophages of the reticulo-endothelial system has been reported by others in the past 
[43]. QD-OH nanoparticles were surprisingly as inert as QD-Micelle and showed reduced 
leukocyte interaction. As majority of lymphocytes are non-phagocytic we see a reduced 
fluorescence signal from these cells. We observed that Granulocytes, which are 
predominantly composed of neutrophils (also professional phagocytes), did not interact 
with QD-COOH as strongly as monocytes. It may be argued that the greater protein 
adsorption and QD-COOH aggregation would expedite size-dependent uptake by 
monocytes. However, the same does not hold true for QD-OH which were also shown to 
aggregate in presence of plasma proteins. Interestingly, when QDs were incubated in 
leukocyte suspensions without plasma proteins, granulocytes showed a 5-fold increase 
in association with QD-COOH compared to monocytes (Figure 6). Clearly, the absence 
or presence of nanoparticle binding proteins modulates the behavior of both monocytes 
and granulocytes. All three QDs are single and non-aggregated in these conditions and 
therefore may prevent recognition and uptake by monocytes. Moreover, phagocytosis 
capability of monocytes is affected as opsonins are absent and cannot coat the 
nanoparticles. The spatial location and mode of internalization cannot be determined 
through flow cytometry. In order to further understand the apparent inertness of QD-OH 
cells were imaged using fluorescence microscope. Also, internalization patterns of QD-
COOH in the presence and absence of plasma were studied. 
Single cell microscopy 
 Leukocyte cell types were pre-sorted using fluorescence-activated cell sorting 
(FACS) and incubated with QD-OH, QD-COOH and QD-Micelle under differing 
conditions. Approximately, 1 million (1 x 106) QDs per cell were used for these studies, a 
number based on initial calculations and preliminary results.  
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Figure 6.7: Single cell microscopy of QD uptake by leukocytes (presence of plasma) as a 
function of temperature and QD surface coating. QD samples are incubated with cells in 
presence of human plasma proteins for 24 hours. 
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Figure 6.8: Single cell microscopy of QD uptake by leukocytes (absence of plasma) as a 
function of temperature and QD surface coating. QD samples are incubated with cells in 
absence of human plasma proteins for 24 hours. 
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 As several endocytic mechanisms, such as phagocytosis, and certain forms of 
pinocytosis, are energy-dependent, we attempted to compare patterns of internalization 
at 37C to those at 4C. Further, leukocytes were incubated in the presence (Figure 7) or 
absence (Figure 8) of plasma proteins to examine difference in QD localization through 
protein interactions. As representative images of single cells are shown, the results offer 
a qualitative assessment of QD uptake or membrane association and cannot be used to 
quantify nanoparticle association. For cells incubated with plasma, QD-COOH 
nanoparticles were strongly associated with monocytes and granulocytes. Although, 
granulocytes appear to internalize more QDs than monocytes (Figure 7), it should be 
noted that there the duration of incubation in this study was 24 hours, compared to 3 
hours in flow cytometry based studies. Therefore, cell images cannot be used to quantify 
QD uptake. More importantly, the results from these experiments confirm that –OH 
coated QDs behave as inert as PEGylated QD-Micelles and resist uptake or non-specific 
association with any type of leukocyte. This observation also reinforces the importance 
of surface coatings in nanoparticle binding with cells.  
 QD-COOH association with cells didn’t change considerably at 4°C compared to 
37°C, except in the case of granulocytes incubated without plasma.. Here, we clearly 
see QD compartmentalization in the peri-nuclear region of the cell. Recent observations 
in our group (Agrawal and Nie, unpublished) have observed expedited transport of 
negatively-charged nanoparticles to the MTOC (Microtubule Organizing Center), which 
is also located in the peri-nuclear region of the cell. 
Time-dependence of QD-Cell Association 
 The association of QDs with three types of leukocytes was studied as a function 
of time for the three types of surface coatings.  
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Figure 6.9: Time-dependent association of QDs with leukocytes as a function of QD 
surface coatings. Association kinetics shown for (A) Monocytes, (B) Lymphocytes and (C) 
Granulocytes. 
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Cells were incubated with a fixed concentration of QDs (106 QDs per cell) at 
room temperature in the absence of plasma proteins. The fluorescence intensity of the 
QD-cell suspension was immediately measured. After a fixed time interval, cells were 
centrifuged and supernatant’s fluorescence was measured. The main assumption was 
that QDs that interacted with cells would be removed from solution after centrifugation 
and a drop in fluorescence would be proportional to association or uptake by cells. The 
percentage of nanoparticle-cell association was calculated and plotted as a function of 
time (Figure 6.9). 
 Consistent with other results, we see a strong association of QD-COOH with 
cells and a typical saturation curve that is normally expected in time-dependent uptake 
measurements. This association is irrespective of cell type but is stronger in 
granulocytes as seen by the steeper slope. QD-Micelle are moderately associated with 
the three cell types whereas QD-OH seem to temporarily associate and then surprisingly 
dissociate from the cells. So far, such a behavior has not been reported in literature, 
although one could speculate the possible causes. First, a photo-brightening of QDs 
over time may cause increase in fluorescence intensity leading to a negative 
association. This possibility can be ruled out because fluorescence intensity of the same 
batch of QDs in similar conditions remained constant up to 24 hours. Second, QD-OH is 
associating with the cells and then being exocytosed over time. Third, membrane 
blebbing of cells due to apoptosis may cause internalized QDs, or QDs bound to the 
membrane to be shed or released in solution after centrifugation. Although this may be 
possible, a similar trend should appear in the other samples, especially QD-Micelle.  
 In conclusion, we have systematically examined the interactions and behavior of 
nanoparticles with different types of leukocytes under various conditions and as a 
function of surface charge. QDs are ideal nanoparticles for understanding how 
nanoparticles interface with components of whole human blood because of their superior 
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fluorescent properties. We studied three types of QD surface-coatings, QD-COOH, QD-
OH, and QD-Micelle and observed that hydroxyl modification of QDs (QD-OH) render 
inertness to a nanoparticle. This inertness is surprising considering the strong adsorption 
of proteins on the QDs, and the subsequent aggregation. 
 Subtle surface modifications and their effects on nanoparticle behavior will 
enable one to engineer non-immunogenic nanomaterials that are much smaller than 
bulky PEG-modified nanoparticles. As our understanding of protein-nanoparticle 
interactions expands, the role of proteins in determining in vivo fate will be important in 
developing a new class of nanoparticles for whole blood assays and targeted drug 
delivery. Further, it will be important to assess how ex vivo interactions as described in 
this chapter compare to interactions in vivo. In the future, the outcome of this study will 
allow for the design of magnetic nanoparticles for selectively capturing rare circulating 
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SUMMARY AND FUTURE DIRECTIONS 
7.1 Summary 
 In this dissertation, we have described methods for the integration of optical and 
magnetic nanoparticles and demonstrated relevant applications for the detection and 
monitoring of cancer. Apart from preventive methods, early detection of cancer 
represents the best strategy to reduce mortality rates, which have not changed for the 
past several decades. In most cases, early detection will involve detecting a low number 
of molecules or cells associated with the disease, therefore, new technologies need to 
be developed that will allow standardized tests to be performed in a clinical setting with 
high detection sensitivity. For detection with high sensitivity, we need bright and stable 
fluorophores that can allow multiplexed assays through target encoding, 
spectrophotometric detection of captured molecules, and multicolored profiling of a panel 
of biomarkers on cells. Quantum dots and dye-doped nanobeads have been developed 
over the last decade and have been successfully used in a myriad of applications[1-8]. 
Also, we need a technology to permit capture and enrichment of target molecules and 
cells in a quick, efficient and reproducible manner. Magnetic nanoparticles have been 
used in the past for separation applications with great success, and can permit semi-
automated assays for capturing target molecules or cells.  
 In the first few chapters of this dissertation, we describe the rationale behind our 
study, define the scope of the studies (Chapter 1) and offer a brief overview of each of 
these technologies, previous related studies, and a description of the issues being 
tackled (Chapter 2). In Chapter 3, we describe methods for developing a new class of 
dual-function beads that are optically encoded and magnetically separable. It was found 
that using mesoporous beads, we could precisely dope beads with magnetic 
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nanoparticles and semiconductor Quantum Dots (QD), but with increased amounts of 
magnetic iron oxide nanoparticles, a drastic reduction in fluorescence intensity of 
embedded QDs was seen. Through systematic studies, we revealed that the strong 
absorption of light by iron oxide was responsible for this attenuation[7]. Following this 
method development, we developed a bead-based sandwich immunoassay (Chapter 4) 
using magnetic beads (not optically encoded) and luminescent nanoparticles (QDs and 
dye-doped nanobeads). From this study, we were able to demonstrate femto-molar 
detection sensitivity of a protein TNF-alpha with a dynamic range of 2-3 logs[2].  
 In the next two chapters (Chapter 5 and 6) we discuss integration of magnetic 
and optical nanoparticles for potential cancer monitoring applications. In particular we 
have demonstrated multiplexed profiling for circulating tumor cells isolated from whole 
blood. These cells have been shown by several groups to be highly sensitive indicators 
of prognosis in metastatic cancer patients [9-12]. Therefore, by characterizing the 
captured cells for molecular biomarkers, there is potential for therapy monitoring and 
administration of tailored and personalized treatment. Specifically, we have made an 
attempt to demonstrate multicolor protein profiling of the magnetically captured cells 
from whole blood for the first time(Chapter 5). Using prostate cancer cell lines showing 
an epithelial to mesenchymal transition (EMT), we were able to isolate the spiked cells 
from phosphate buffer and blood, and label two biomarkers using QDs that allowed us to 
determine the phenotype and behavior of the cells. Further, breast cancer cell lines 
isolated from blood were profiled for three commonly used breast cancer markers that 
would determine treatment regimen. Through the course of this study, we also 
encountered that immunomagnetic nanoparticles were non-specifically isolating non-
tumor leukocytes along with tumor cells. This issue was addressed by using brightly 
fluorescent QDs to probe the interactions between nanoparticles and components of 
peripheral blood as a function of surface properties (Chapter 6). The importance of this 
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study is not limited to non-specific capture of nanoparticles in whole blood assays, but 
also to assess immunological properties of nanoparticles and how they can be 
modulated for targeted in vivo applications. Interestingly, we observed a plasma-protein 
mediated cell specific uptake of negatively-charged QDs (QD-COOH) through flow 
cytometry. Carboxylated QDs were strongly associated with monocytes when incubated 
in whole blood containing proteins, whereas they were associated with granulocytes in 
the absence of the proteins. Surprisingly, hydroxyl-modified QDs (QD-OH) behaved as 
inert as PEGylated micellar QDs by not associating with granulocytes, monocytes or 
lymphocytes in the presence or absence of proteins. This finding may open avenues for 
a new class of polymer-coated nanoparticles that are biocompatible and can accumulate 
in target organs with minimum biodistribution in un-targeted organs. 
7.2 Discussion and Future Directions 
Near-IR QD encoded dual-function beads 
 From our studies, it is clear that the broad absorption spectrum of iron oxide 
attenuates fluorescence signal from embedded QDs. This observation can be 
detrimental for accurate decoding of beads after magnetic isolation. However, the iron 
oxide nanoparticle absorption spectrum (see Figure 3.6A) tapers at longer wavelengths, 
and the absorbance is almost negligible at wavelength of 750 nm and above. Therefore, 
hydrophobically capped near-IR QDs with emission peak greater than this value have 
the potential to permit optical bead encoding without concern of signal attenuation.  
Mesoporous bead surface capping 
 We have demonstrated coating of dual-function beads, discussed in Chapter 3, 
with a combination of amphiphilic polymers and surfactants. This procedure has allowed 
the beads to remain stable for up to 45 days. However, we have not been able to 
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confirm the presence of the polymer on the surface. Further work needs to be done to 
characterize the polymer coating and determine availability and surface density of 
functional groups to permit attachment of targeting ligands. Apart from polymers, we also 
see the potential to grow a silica shell on the silica microbeads using alkylated silanes 
and orthosilicates. Currently, we are pursuing experiments to grow a silica shell with 
epoxy groups on the surface, so that they can be coupled to amine-rich IgG molecules. 
Preliminary results are encouraging, but more careful characterization needs to be done. 
Simultaneous bead-based DNA and protein detection 
   Although we have demonstrated detection of protein with high sensitivity using 
magnetic bead enrichment and target labeling with luminescent nanoparticles, there is a 
need to develop beads and probes so that multiple target DNA molecules and proteins 
can be detected using the same assay and conditions. Such an assay would save time 
and would allow a clinician to monitor the levels of molecules implicated with the tumor 
or monitor molecules that can provide information on the side effects of a therapeutic 
agent. 
Uniform magnetic nanoparticles for separation applications 
 We have briefly described the application of uniform magnetic nanoparticles for 
cell separation purposes. Compared to the gold standard of magnetic separation (150 
nm magnetic nanoparticles produced by Immunicon Inc.), the nanoparticles generated 
by us are smaller uniform and have larger contact area to the increase in surface-area to 
volume ratio. Since the total magnetic mass present on the captured cell will determine 
its mobility towards a magnet, there is potential for smaller nanoparticles with uniform 
magnetization to improve separation efficiency. Further, when using multiple QDs for 
biomarker labeling, smaller magnetic nanoparticles on the cell will not pose steric 
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hindrance problems associated with larger magnetic nanoparticles. This is especially 
important for accurately determining the relative amounts of biomarkers in the cell.   
 Also, further work must be done to test whether a cocktail of antibodies attached 
to magnetic nanoparticles that are specific to epithelial cells will improve specificity. A 
major hurdle to this effort would be preventing non-specific binding to leukocytes, which 
has been discussed in Chapter 5. It should also be noted that even though non-
specificity of nanoparticles to leukocytes can be obtained by engineering the 
nanoparticle surface, low level expression of EpCAM by a few leukocytes may still cause 
the unwanted interference by these cells. Therefore, negative depletion of leukocytes 
may be considered as long as tumor cells are not lost in the process. Typically, a test 
involving the least number of washing steps and sample transfer will reduce probability 
of cell loss. It is crucial in this respect that cells are not lost since enumeration of cells is 
closely linked to prognostic factors[13]. 
Understanding implications of QD protein interactions 
 An interesting observation from the studies described in Chapter 6 is that non-
specific association of hydroxyl-modified QDs (QD-OH) is drastically reduced compared 
to carboxylated QDs (QD-COOH). However, both QD coatings tend to bind strongly to 
plasma proteins. This is clearly evident from gel shift assays and fluorescence 
microscope images where particles are clearly aggregated. It is thought that protein 
adsorption will ultimately decide the fate of the nanoparticle. Why QD-OH nanoparticles 
still inhibit association even after protein coating is an intriguing question and needs to 
be understood. The possibility of nanoparticle exocytosis is speculated but more in-
depth studies to visualize this process using live cell imaging procedures need to be 
performed. Also, blood compositions varies substantially from person to person, 
therefore future studies must keep in mind these issues when studying protein-
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nanoparticle interactions. Further studies to examine nanoparticle interactions with 
platelets were not included in this work and may provide a complete picture of the 
immunological properties of nanomaterials. Whether our observations will mimic the 
interactions in vivo cannot be concluded, but provide a basis for future studies.  
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